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TITLE 
 
A systematic review of randomized-controlled trials evaluating mindfulness-based 
psychological therapies for psychosis 
 
 
ABSTRACT  
 
Background: Mindfulness-based psychological therapies are increasingly used with 
people with psychosis-spectrum disorders. They have been suggested to have 
potential to improve outcomes for this group. A number of randomized-controlled 
trials (RCTs) have now been conducted to assess their effectiveness.  
Objective: To identify, summarize and evaluate RCTs comparing a mindfulness-
based intervention to a control condition for people with psychosis-spectrum 
disorders to determine their efficacy for this population.  
Data sources: A systematic review of articles identified by searching MEDLINE, 
EMBASE, PsychINFO, PsychARTICLE, CINAHL, Google Scholar, and Clinical 
Trial Registers (e.g. Cochrane Central Register of Controlled Trials, Current 
Controlled Trials Ltd.) from < 1980 to May 2014. Additionally, relevant journals and 
reference lists were hand-searched and clinical experts contacted to identify eligible 
studies. 
Results: A total of 12 articles describing 11 studies were identified, comprising a 
total of 599 participants with affective and non-affective psychotic disorders, with a 
mean age of 36.5 years (range 25.8 – 43.2).  54.2% of the sample were male. The 
interventions included Mindfulness training, Mindfulness-based Cognitive Therapy, 
Acceptance and Commitment Therapy, Compassion Focused Therapy, Dialectical 
Behaviour Therapy, amongst others. The descriptive summary of study 
characteristics and outcomes indicated significant heterogeneity between studies. 
Furthermore, evaluation of risk of bias using the Cochrane Collaboration Risk of 
Bias tool indicated significant risk of bias amongst included studies, with only three 
being rated as low risk while the remaining eight studies were rated as having high 
risk of bias.  
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Conclusion: High levels of heterogeneity between and high risk of bias within 
individual studies make it difficult to determine efficacy of and draw conclusions 
about the use of mindfulness-based interventions for psychosis-spectrum disorders at 
this point. Further research comprising larger samples and more standardized use of 
interventions is needed to be able to compare studies more meaningfully in order to 
determine clinical implications.  
 
Keywords: psychosis, mindfulness, RCT, systematic review 
 
 
INTRODUCTION 
 
 There is now consistent evidence that Cognitive Behavioural Therapy for 
psychosis (CBTp) is associated with robust small to moderate effects on outcomes 
including overall psychiatric symptoms (Jauhar et al., 2014), positive symptoms 
(Wykes et al., 2008), delusions and hallucinations (van der Gaag et al., 2014). 
Recent guidance from the National Institute for Health and Care Excellence (NICE, 
2014) recommends CBT as an individual treatment in psychosis particularly where 
there are persisting positive and negative symptoms. Since these pioneering studies 
of CBTp, there has been increasing interest in mindfulness-based psychological 
therapies.  
 Mindfulness-based Cognitive Therapy (MBCT, Segal et al., 2002), 
Mindfulness-based Stress Reduction (MBSR) therapy (Kabat-Zinn, 1990), 
Acceptance and Commitment Therapy (ACT, Hayes et al., 1999), Compassion 
Focused Therapy (CFT, Gilbert, 2009), Loving-kindness meditation (Salzberg, 
1995), and  Dialectical Behaviour Therapy (DBT, Linehan, 1993) can be seen as 
falling under the category of mindfulness-based psychological therapies. These 
approaches vary in their components and main foci (e.g. meditation-based, 
acceptance-based or compassion-based) but what they all have in common is an 
emphasis on alleviating psychological distress by changing one’s relationship to 
thoughts and feelings (as opposed to challenging them as in traditional CBT) by 
cultivating a mindful, non-judgemental attitude to one’s experiences. For this 
purpose, they all tend to include some form of meditation practice (e.g. retraining 
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attention by using mindfulness meditation), behavioural practice (e.g. taking a 
loving-kindness stance towards self and others), and cognitive strategies (e.g. 
reflection on transitory nature of events) aimed at training the mind in order to 
manage and reduce distressing affect (Singh et al., 2008). Mindfulness is an 
important ingredient in all of these approaches.  
 Previous systematic reviews provided evidence that some third-wave 
approaches or aspects of them when combined with treatment as usual (TAU) are 
helpful in reducing symptom-related distress and re-hospitalisation rates in people 
with psychotic disorders, as well as increasing feelings of self-efficacy (Davis & 
Kurzban, 2012; Helgason & Sarris, 2013). However, these studies only looked at 
mindfulness and meditation approaches used in combination with other routine 
treatment. In a recent systematic review, Khoury et al. (2013) combined the results 
of studies exploring the effectiveness of mindfulness-based psychological therapies 
in the treatment of people with psychotic disorders, used exclusively rather than in 
combination with another psychological intervention. The authors concluded that 
mindfulness-based interventions have a moderate effect with regards to treating 
negative symptoms, and can be beneficial when combined with pharmaceutical 
treatment (Khoury et al., 2013). A significant limitation of this review was the 
inclusion of uncontrolled and non-randomized trials. Almost half of the studies 
included did not use a control group, which makes it difficult to draw clear 
conclusions about effectiveness of an intervention.  
 
Aim of the study 
Therefore the current study aimed to build on previous reviews by undertaking a 
review of randomized-controlled trials (RCTs) of mindfulness-based therapeutic 
approaches in the treatment of psychosis-spectrum disorders, addressing the 
following questions:  
 
1. What is the evidence for mindfulness-based approaches improving outcomes 
for people with affective and non-affective psychosis/psychosis-spectrum 
disorders compared to any control? 
2. What is the evidence regarding risk of bias amongst those studies included in 
the review? 
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METHODS 
 
Eligibility criteria 
 Inclusion criteria: studies that i) included participants with a diagnosis of an 
affective or non-affective psychosis-spectrum disorder (e.g. schizophrenia, 
schizoaffective disorder, bipolar disorder, first-episode psychosis etc), ii) compared a 
mindfulness-based therapeutic approach (e.g. ACT, MBCT, CFT, DBT, or any other 
mindfulness-based approach) with a comparator (e.g. TAU), iii) used a randomised-
controlled trial (RCT) design, and iv) were published in peer-reviewed journals 
between 1980 and May 2014. No language restrictions were imposed. No limits were 
placed on age of participants or severity or duration of illness.  
 Exclusion criteria: studies that i) included participants with a primary 
diagnosis of non-psychotic psychiatric disorders, learning disability, psychosis 
secondary to a general medical condition or organic pathology, or a primary 
diagnosis of substance-induced psychosis, (ii) were using a study design other than 
RCT, i.e. non-clinical/analogue, uncontrolled, observational, qualitative or case 
studies, iii) were unpublished.  
 
Outcomes 
 Outcomes included General clinical improvement, Psychiatric symptom 
changes, Rehospitalisation/crisis contacts, Depression and Anxiety, Social 
Functioning and Quality of life, Positive and Negative Affect, and Processes and 
mechanisms of change as relevant to the studies included in the review. 
  
Search strategy 
 Studies were identified by searching electronic databases and trial registers, 
and by manually searching reference lists of eligible articles and journals. No limits 
were applied for language or date of publication. The search was completed in May 
2014. The following computerized databases were searched: Ovid MEDLINE (R) 
In-process & Other Non-indexed Citations and Ovid MEDLINE (R) < 1980 to May 
2014; EMBASE < 1980 to May 2014;  PsychINFO < 1980 to May 2014; 
PsychARTICLE < 1980 to May 2014; CINAHL < 1980 to May 2014; and Google 
Scholar < 1980 to May 2014. The last search was run on May 18
th
 2014. In addition, 
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Clinical Trial Registers (Cochrane Central Register of Controlled Trials 
(CENTRAL), ClinicalTrials.Gov, Current Controlled Trials Ltd., and the Australian 
and New Zealand Clinical Trials Registry) were also searched. The following search 
terms were used: Mindfulness or meditat*; Mindfulness-based; acceptance and 
commitment therapy; acceptance-based; compassion; compassion-focused; 
compassionate mind training; loving-kindness; person-based cognitive therapy; 
dialectical behaviour therapy; third-wave therap* combined with psychosis or 
psychotic; psychotic disorder*; schizophreni*; schizoaffective disorder*; 
schizophrenia-spectrum disorder*; bipolar disorder*; manic depression. See 
Appendix 1.2 for example of electronic search. 
 Hand searches of journals (e.g. British Journal of Clinical Psychology, 
Behaviour Research and Therapy, Schizophrenia Bulletin) and references of 
pertinent articles were undertaken following the electronic search to ensure no 
relevant articles were missed. Following identification of the final list of eligible 
studies, experts in the field were consulted with regards to its completeness.  
 
Study selection 
 Assessment for the purpose of study selection was undertaken primarily by 
the author (JH) and involved the screening of titles and abstracts of all search results 
in the first instance. The application of predefined eligibility criteria aided the 
exclusion of studies. Further exclusions were made following the screening of full-
text articles, aided by consultation with an independent reviewer (AG). The list of 
studies to be included was finalized following consultation with experts in the field.  
 
Data Extraction 
 A data extraction sheet was developed based on the Cochrane Consumers and 
Communication Review Group’s data extraction template (2013). The extraction 
sheet was pilot-tested on two of the included studies (selected randomly), reviewed 
by an independent reviewer (AG) and refined accordingly (Appendix 1.3). 
Information extracted from each trial included characteristics of trial participants, 
methodology (including recruitment and allocation process, type of interventions, 
and type of outcome assessment), and results of the study. As outlined above, 
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information on risk of bias was also collected and included in a separate Risk of Bias 
form.  
 
Assessment of risk of bias in included studies  
 All studies selected were assessed for risk of bias using the Cochrane 
Collaboration Risk of Bias tool (Higgins et al., 2011a) to ascertain the validity of 
estimated treatment effect. The use of this tool is recommended by The PRISMA 
Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That 
Evaluate Health Care Interventions (Liberati et al., 2009). This involved assessing 
the studies for potential sources of bias in areas that have been found to skew 
estimation of treatment effect, namely allocation of participants (i.e. sequence 
generation and allocation concealment), blinding, completeness of outcome data, 
selective outcome reporting and any other source of bias (e.g. baseline imbalance) 
threatening internal validity. A data extraction sheet was developed accordingly 
(Appendix 1.4). Nine of the studies were rated independently by two reviewers (JH 
and AG), using the extraction sheet. Inter-rater agreement was achieved by resolving 
any disagreements in discussion between them, where necessary. The remaining two 
studies were rated by one reviewer (JH) only because the second reviewer (AG) had 
been involved in these studies and could therefore not give independent judgement. 
Furthermore, trial reports were compared to original trial register protocols, where 
available, to assess for other potential sources of bias (e.g. any post hoc decisions 
made by authors).  The outcome of this assessment overall was used to judge the 
quality of individual studies and the validity of the evidence provided by them. This 
was included in the synthesis of the studies, informing the conclusions drawn from 
this review with regards to the overall evidence-base. 
 
Synthesis of results 
 Synthesis of the results included a summary of the characteristics of included 
studies (including participants, interventions, methodology and risk of bias). The 
outcomes of the studies were summarized by grouping them under areas of outcome 
and measures used (e.g. psychiatric symptoms, therapy-specific outcomes etc), and 
reporting the overall results accordingly. This approach to synthesis was deemed 
appropriate and most meaningful given the heterogeneity of included studies. 
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RESULTS 
 
Search and study selection 
 The search and study selection process is summarized in Figure 1 below. The 
initial search of electronic databases using the search terms outlined above resulted 
in 840 titles initially, 564 once duplicates were removed. Of these, 468 were 
excluded following screening of titles because it appeared that they clearly did not 
meet the criteria (e.g. being non-clinical, not pertaining to either a psychosis-
spectrum sample or mindfulness-based approach, or addressing a completely 
different area). Applying the eligibility criteria, the abstracts of the remaining 96 
studies were then assessed, which resulted in another 65 exclusions. Reasons for 
exclusions are outlined below (Fig. 1).  
 The full-text manuscripts of the 31 included studies were then screened. 
Before further exclusions were made the abstracts of these studies were reviewed by 
another reviewer (AG) and agreement reached on the final number of studies to be 
included in the review. Of these 31 manuscripts, 20 were excluded from selection 
leaving 11 manuscripts describing 10 studies for inclusion into the review. Manual 
screening of the reference lists of these studies and hand-search of relevant journals 
did not result in any further studies to be included. Before synthesis was undertaken, 
feedback was sought on the final list of studies from experts in the field of ACT, 
CFT and mindfulness-based approaches. This generated one trial that recently had 
been published online to be included.  
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Figure 1: Flowchart of the article selection process 
 
 
 
 
Included studies 
 In total, 12 manuscripts describing 11 studies met inclusion criteria: Bach & 
Hayes (2002) and Bach, Hayes & Gallop (2012); Braehler, Gumley, Harper, 
Wallace, Norris & Gilbert (2013); Chadwick, Hughes, Russell, Russell & Dagnan 
(2009); Chien & Lee (2013); Chien & Thompson (2014); Gaudiano & Herbert 
(2006); Langer, Cangas, Salcedo & Fuentes (2011); Perich, Manicavasagar, 
Mitchell, Ball & Hadzi-Pavlovic (2013); Shawyer, Farhall, Mackinnon, Trauer, 
Sims, Ratcliff, Larner, Thomas, Castle, Mullen & Copolov (2012); Van Dijk, Jeffrey 
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& Katz (2013); White, Gumley, McTaggart, Rattrie, McConville, Cleare & Mitchell 
(2011).  The included studies are summarized in Table 1.  
 
Study/participant characteristics 
 Combined the studies comprised a total of 599 adult participants (before 
attrition rates), with an average of 54 participants per study (range 22-107). Based on 
data from ten studies, the mean age of the participants was 36.5 years (range 25.8 – 
43.2). No data were provided on the age of 95 participants (15.9%) (Perich et al. 
2012). Based on nine studies, 54.2% (n=300) of the sample were male, while 45.8% 
(n=254) were female. Two studies (Chadwick et al., 2009, Langer et al., 2011; n=45, 
7.5%) did not provide information on gender. Information on ethnicity was provided 
by four studies (n= 187; 31.2%) and included Caucasian non-Hispanic (n=60) (Bach 
& Hayes, 2002/Bach et al., 2012), African-American (n=36) (Gaudiano & Herbert, 
2006) and White British (n=66) (Braehler et al., 2012; White et al., 2011). Four 
studies stated country of birth, with participants born in China (n=203; 33.9%) 
(Chien & Lee, 2013; Chien & Thompson, 2014), Spain (n=23; 3.8%) (Langer et al., 
2011), Australia (n=138; 23.0%) (Perich et al., 2013; Shawyer et al., 2012) and 
Canada (n=26; 4.3%) (Van Dijk et al., 2013). One study did not provide any 
information on ethnic background/country of origin (n=22; 3.7%) (Chadwick et al., 
2009). Inclusion criteria were stated by all 11 studies.  
 Nine studies provided detailed information on diagnoses within their 
samples. These included primary diagnoses of schizophrenia (n=324; 54.1%), other 
non-affective psychosis (n=10; 1.7%), schizoaffective disorder (n=35; 5.8%), 
schizoaffective disorder manic type (n=1; 0.2%), mood disorder with psychotic 
features (n=32; 5.3%), depressive psychosis (n=9; 1.5%), bipolar disorder with 
psychosis (n=2; 0.3%), delusional disorder (n=5; 0.8%), psychosis NOS (n=10; 
1.7%), bipolar disorder mania and psychosis (n=1; 0.2%), bipolar disorder 
depression and psychosis (n=2; 0.3%), bipolar disorder type I (n=69; 11.5%), bipolar 
disorder type II (n=49; 8.2%), bipolar NOS (n=1; 0.2%).  
 Secondary diagnoses included anxiety disorder (n=83; 13.9%), substance 
related disorder (n=38; 6.3%), borderline intellectual functioning (n=10; 1.7%), 
personality disorder (n=19; 3.2%), ADHD (n=3; 0.5%), and major medical condition 
(n=33; 5.5%). Two studies (Gaudiano & Herbert, 2006; Langer et al 2011) did not 
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provide detailed information other than broad the diagnostic term of ‘psychotic 
disorder’ (n=63; 10.5%). Medication was reported by eight studies, while three 
studies omitted this information (Bach & Hayes, 2002/Bach, Hayes & Gallop, 2012; 
Shawyer et al., 2012; White et al., 2011). Information on educational level was 
explicitly stated for 58.9% (n=353) of the total sample by five studies (Chien & Lee, 
2013; Chien & Thompson, 2014; Gaudiano & Herbert, 2006; Perich et al., 2013; 
White et al., 2011). Employment status for 239 participants (39.9%) was reported by 
six studies (Chadwick et al., 2009; Gaudiano & Herbert, 2006; Langer et al, 2011; 
Perich et al., 2013; Shawyer et al., 2012; White et al., 2011), with 65.3% (n=156) of 
these participants being unemployed, 30.4% (n=73) in full-time or part-time 
employment, 3.8% (n=9) working causally or unpaid, and 0.3% (n=1) studying.  
 Most studies used a purposive/convenience sampling approach, recruiting 
from various sites, including psychiatric inpatient (20%; n=120) (Bach & Hayes, 
2002/Bach et al., 2012; Gaudiano & Herbert, 2006), community mental health 
services/outpatient clinics (38.1%; n=228) (Braehler et al., 2013; Langer et al., 2011; 
Shawyer et al., 2012; Van Dijk et al., 2013), and local community (15.8%; n=95) 
(Perich et al., 2013). Two studies (33.9%; n=203) attempted to recruit representative 
samples from the wider population by randomly selecting from all eligible 
participants in the area (Chien & Lee, 2013; Chien & Thompson, 2014). One study 
(White et al., 2011) did not provide exact figures, but recruited its sample (n=27; 
4.5%) from various sites (community mental health teams, early intervention 
services for psychosis, a medium-secure forensic service, and psychiatric 
rehabilitation services). One study (Chadwick et al, 2009; n=22; 3.6%) did not 
specify recruitment site. Seven studies included a flow-chart of the recruitment 
process and participant flow (Braehler et al., 2012; Chadwick et al, 2009; Chien & 
Thompson, 2014; Gaudiano & Herbert, 2006; Perich et al., 2013; Shawyer et al., 
2012; White et al., 2011). Attrition rate was reported by all eleven studies, with eight 
providing further explanations for attrition (Bach & Hayes, 2002/Bach et al., 2012; 
Braehler et al., 2012; Chadwick et al, 2009; Chien & Thompson, 2014; Gaudiano & 
Herbert, 2006; Langer et al., 2011; Perich et al., 2013; Shawyer et al., 2012). Only 
one study compared the characteristics of the participants who defaulted from 
treatment (White et al., 2011). 
 
  
 
12 
 
Table 1: Study Characteristics 
 
              
Study Type participants (n)  Age 
(mean 
years)
  
Gender  
(male %) 
Treatment 
group  
(n = 
total/after 
attrition) 
 
Comparis
on 
group(s) 
(n = 
total/after 
attrition) 
 
Attrition  
(Total % / 
treatment 
group %) 
Number 
of 
sessions 
Follow-
up 
(months) 
Outcome 
measures 
Results 
Bach & 
Hayes 
(2002) 
 
 
 
 
 
 
Bach et 
al (2012) 
Inpatients (80) with 
schizophrenia/ psychosis 
diagnosis, experiencing positive 
symptoms  
 
- North American 
 
 
 
(n=51 of original n=80 available 
for 1 year FU) 
 
39.35 
 
 
 
 
63.75 ACT + TAU 
(40/35) 
(individual)  
 
 
 
 
 
 
n=36 
remained  
TAU 
(40/35) 
12.5 /12.5 4 
-  45-50 
min each 
4  
 
 
 
 
 
 
 
 
12 
Hospitalisation 
rate; 
Self-rating  of 
psychotic 
symptoms 
(frequency, 
distress and 
believability of 
symptoms) 
 
ACT group had significantly lower rate of 
rehospitalisation at 4 month follow-up and 
showed significantly higher symptom reporting 
and lower symptom believability when 
compared to TAU. 
 
 
 
 
Participation in ACT was significantly 
associated with reduced rehospitalisation at 1 
year post discharge after controlling for length 
of previous and current hospitalization. 
 
Braehler 
et al. 
(2012) 
 
 
 
 
 
 
 
Outpatients (40) with 
schizophrenia-spectrum disorder 
diagnoses  
 
- British (Scottish) 
 
 
 
 
 
 
 
41.76 55 CFT+TAU 
(22/18) 
(group) 
TAU 
(18/17) 
12.5 / 18 16 
(average of 
12 
attended) 
- 2 hrs 
each   
 
N/A Narrative 
Recovery Style 
Scale (NRSS); 
Clinical Global 
Impression-
Improvement 
Scale (CGI-I);  
Personal Beliefs 
about Illness 
Questionnaire 
(PBIQ-R);  
Fear of 
Recurrence Scale 
CFT was associated with significantly greater 
observed clinical improvement and significant 
increases in compassion.  
 
Increases in compassion were significantly 
associated with reductions in depression and in 
perceived social marginalization. 
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Study Type participants (n)  Age 
(mean 
years)
  
Gender  
(male %) 
Treatment 
group  
(n = 
total/after 
attrition) 
 
Comparis
on 
group(s) 
(n = 
total/after 
attrition) 
 
Attrition  
(Total % / 
treatment 
group %) 
Number 
of 
sessions 
Follow-
up 
(months) 
Outcome 
measures 
Results 
(FoRSe);  
Positive and 
Negative Affect 
Scale (PANAS);  
BDI-II 
 
Chadwic
k et al. 
(2009) 
Outpatients (22) with 
schizophrenia diagnosis, 
experiencing distressing 
psychotic experiences (voices or 
delusions) 
 
- British  
41.6 Missing MT (11/9) 
(group) 
WL (11/9) 14  / 18 10 sessions 
(average of 
6 attended) 
- length of 
session not 
stated 
 
 + 5 weeks 
of home  
 
 
Practice 
(not 
formally 
assessed)  
N/A Clinical Outcomes 
in Routine 
Evaluation (CORE) 
Southampton 
Mindfulness 
Questionnaire 
(SMQ), 
Southampton 
Mindfulness 
Voices 
Questionnaire 
(SMVQ) 
 
 
Psychiatric 
Symptom Rating 
Scale (PSYRATS) 
Beliefs about 
Voices 
Questionnaire 
revised (BAVQ-r) 
Participants in the mindfulness group showed 
significant improvement in clinical functioning 
and mindfulness of distressing thoughts and 
images post-intervention, however, no change 
was observed in psychotic symptoms and 
beliefs about voices. Effects not significant at 
group comparison level.  
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Study Type participants (n)  Age 
(mean 
years)
  
Gender  
(male %) 
Treatment 
group  
(n = 
total/after 
attrition) 
 
Comparis
on 
group(s) 
(n = 
total/after 
attrition) 
 
Attrition  
(Total % / 
treatment 
group %) 
Number 
of 
sessions 
Follow-
up 
(months) 
Outcome 
measures 
Results 
Chien & 
Lee 
(2013) 
Outpatients (96) with 
schizophrenia diagnosis 
 
- Chinese  
25.8 55 MBPP + 
TAU 
(48/45) 
(group) 
TAU 
(48/45) 
6 / 6 12 
sessions 
- 2 hrs 
each 
18   Brief Psychiatric 
Rating Scale 
(BPRS) 
Specific Level of 
Functioning Scale 
(SLOF) 
Social Support 
Questionnaire 
(SSQ-6) 
Insight and 
Treatment 
Attitudes 
Questionnaire 
(ITAQ) 
Rehospitalisation 
Attendance of MBPP was associated with 
significant change in symptom severity, illness 
insight, and length of rehospitalisation at post 
intervention, while functioning and number of 
rehospitalisation improved significantly only at 
the 18- month follow-up. 
Chien & 
Thomps
on 
(2014)  
Outpatients (107) with 
schizophrenia diagnosis 
 
- Chinese 
25.8 57 MBPP (36) 
(group) 
 
 
CP (36) 
 
Usual 
Care (35) 
4 / 5.5 12 
fortnightly 
2-hour 
sessions 
24 Brief Psychiatric 
Rating Scale 
(BPRS) 
Specific Levels of 
Functioning Scale 
(SLOF) 
6-item Social 
Support 
Questionnaire 
(SSQ6) 
Insight and 
Treatment 
Attitudes 
Questionnaire 
(ITAQ). 
MBPP group showed significantly greater 
improvement in Insight and Treatment 
Attitudes, Specific Levels of Functioning, Brief 
Psychiatric Rating Scale, and duration of 
hospital readmissions.  
 
No significant effects were noted for Social 
Support and frequency of readmission. 
 
In original trial protocol published on 
ClinicalTrials.Gov frequency of readmissions 
was specified as the primary outcome of the 
study. This was not reported in the published 
manuscript. 
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Study Type participants (n)  Age 
(mean 
years)
  
Gender  
(male %) 
Treatment 
group  
(n = 
total/after 
attrition) 
 
Comparis
on 
group(s) 
(n = 
total/after 
attrition) 
 
Attrition  
(Total % / 
treatment 
group %) 
Number 
of 
sessions 
Follow-
up 
(months) 
Outcome 
measures 
Results 
 
Frequency and 
duration of 
readmissions to 
psychiatric 
hospital over the 
previous 6 or 12 
months at Times 
1–4 were 
collected from 
clinic records.  
 
Gaudian
o & 
Herbert 
(2006) 
Inpatients (40) with psychotic 
disorder or affective disorder 
with psychotic symptoms 
 
- North-American, predominantly 
African-American (88%) 
40 64 ACT+ETAU 
(19/14) 
(individual
) 
ETAU 
(21/15) 
27.5 / 26  5 sessions 
(average of 
3 attended) 
- 1 hr each 
4 (ONLY 
for 
rehospit
alisation
) 
Brief Psychiatric 
Rating Scale 
(BPRS) 
Clinical Global 
Impression-
Improvement 
Scale (CGI-S) 
Self-ratings of 
psychotic 
symptoms 
(frequency, 
distress and 
believability of 
symptoms) 
Sheehan Disability 
Scale (SDS) 
Rehospitalisation  
 
Positive changes in affective severity, global 
improvement, distress associated with 
hallucinations, social functioning, and overall 
clinically significant symptom improvement 
was observed in the ACT group at discharge. 
Frequency or severity of psychotic symptoms 
was not affected. Rehospitalisation rate was in 
favour of ACT (38% reduction), but not 
significant. There was some indication that 
change in believability of hallucination in ACT 
was related to changes in distress.  
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Study Type participants (n)  Age 
(mean 
years)
  
Gender  
(male %) 
Treatment 
group  
(n = 
total/after 
attrition) 
 
Comparis
on 
group(s) 
(n = 
total/after 
attrition) 
 
Attrition  
(Total % / 
treatment 
group %) 
Number 
of 
sessions 
Follow-
up 
(months) 
Outcome 
measures 
Results 
Langer 
et al. 
(2011) 
Outpatients (?) (23) with 
diagnosis of schizophrenia 
spectrum disorders  
 
- Spanish 
34.3 Missing MBCT 
(11/7) 
(group) 
WL 
(12/11) 
17 / 36 8 sessions 
(average 
attendanc
e not 
stated) 
- 1 hr 
N/A  Clinical Global 
Impression-
Schizophrenia 
Scale (CGI-SCH); 
Acceptance and 
Action Scale (AAQ 
II); 
Southampton 
Mindfulness 
Questionnaire 
(SMQ)  
 
No significant effects were observed in any 
measure between the groups, except in 
mindfulness response to stressful thoughts and 
images within the MBCT group.  
Perich et 
al. 
(2013) 
Outpatients (95) with diagnosis 
of bipolar disorder (I, II or NOS) 
 
- Australian  
Missin
g 
34.7 MBCT 
+TAU 
(n=48/34) 
(group) 
TAU 
(n=47/25) 
37% / 29% 8 sessions 
(average 
of 7 
session 
attended) 
3, 6, 9 
and 12  
Young Mania 
Rating Scale 
(YMRS) 
Montgomery-
A˚sberg 
Depression Rating 
Scale (MADRS) 
Composite 
International 
Diagnostic 
Interview (CIDI) 
Depression 
Anxiety Stress 
Scales (DASS)  
State/Trait 
Anxiety Inventory 
(STAI) 
Dysfunctional 
MBCT did not reduce time to recurrence of 
depressive or hypo/manic episodes over a 12-
month follow-up period, nor was it associated 
with a reduction in mood symptom severity 
scores. 
 
However, MBCT was associated with a 
reduction in state and trait anxiety and levels 
of stress, indicating benefits to bipolar disorder 
patients with comorbid anxiety. 
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Study Type participants (n)  Age 
(mean 
years)
  
Gender  
(male %) 
Treatment 
group  
(n = 
total/after 
attrition) 
 
Comparis
on 
group(s) 
(n = 
total/after 
attrition) 
 
Attrition  
(Total % / 
treatment 
group %) 
Number 
of 
sessions 
Follow-
up 
(months) 
Outcome 
measures 
Results 
Attitudes Scale 24 
(DAS-24) 
Response Style 
Questionnaire 
(RSQ) 
Mindful Attention 
Awareness Scale 
(MAAS)  
 
Shawyer 
et al 
(2012) 
Outpatients (?) (43) with 
schizophrenia-spectrum 
disorders   
 
- Australian 
39 56 ABCBT 
(21/19/16
) 
(individual
) 
Befriendin
g 
(22/19/17
) 
23/ 23.8 15 
sessions 
(average 
of 12 
attended) 
- 50 min 
each 
6 Positive and 
Negative 
Syndrome Scale 
(PANSS) 
Selected items of 
Psychotic 
Symptom Rating 
Scales (Auditory 
Hallucinations) 
(PSYRATS)  
Modified Global 
Assessment of 
Functioning scale 
(Modified GAF) 
Quality of Life 
Enjoyment and 
Satisfaction 
Questionnaire  
Voices 
No differences found between groups 
regarding confidence to resist harmful 
commands or in ability to cope with them. 
However, a significant limitation of the stud: 
only 41% of sample reported compliance to 
harmful command hallucinations at baseline.  
 
No significant differences observed between 
the groups in any of the outcomes (i.e. changes 
in illness severity, better functioning, reduction 
in distress, or improvement of quality of life).  
 
No significant therapy-specific differences 
observed between the groups. 
 
Within-group analyses indicated significant 
improvements on positive and negative 
symptomatology, acceptance of auditory 
hallucinations, and significant improvement in 
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Study Type participants (n)  Age 
(mean 
years)
  
Gender  
(male %) 
Treatment 
group  
(n = 
total/after 
attrition) 
 
Comparis
on 
group(s) 
(n = 
total/after 
attrition) 
 
Attrition  
(Total % / 
treatment 
group %) 
Number 
of 
sessions 
Follow-
up 
(months) 
Outcome 
measures 
Results 
Acceptance and 
Action Scale 
(VAAS)  
Subscales of the 
Voices 
Questionnaire-
Revised (BAVQ-R) 
commands 
Insight Scale 
Recovery Style 
Questionnaire 
(RSQ)  
global functioning in treatment group, while 
control group showed significant 
improvements in acceptance of command 
hallucinations. Both groups showed 
improvements in disruption caused by positive 
symptoms and in quality of life. 
Van Dijk 
et al. 
(2013) 
Outpatients (?) (26) with bipolar I 
or II diagnosis  
 
- Canadian 
43.2 25 BDG + 
TAU 
(13/12) 
WL 
(13/12) 
7 / 7 12 sessions 
(average 
attendance 
not stated) 
- 90 min 
each 
N/A Beck depression 
inventory II (BDI 
II) Mindfulness-
based self-
efficacy scale 
(MSES)  
Affective control 
scale (ACS)  
Attenders of DBT group showed significant 
Improvements in affective control and 
mindfulness self-efficacy compared to waitlist 
control. There was also a trend towards 
reduction in depressive symptoms noted in the 
treatment group.  
 
White et 
al. 
(2011) 
Outpatients and inpatients (27) 
with diagnosis of psychosis-
spectrum disorder 
 
- British  
34 77.8 ACT + TAU 
(14) 
(individual
) 
TAU 
(13/10) 
 
11% / 0% 10 
sessions 
(average 
attended 
not 
reported) 
- 1 hour 
each  
N/A Hospital Anxiety 
and Depression 
Scale (HADS)  
Positive and 
Negative 
Syndrome Scale 
(PANSS) 
Acceptance and 
Action 
Questionnaire  II 
Participants in the ACT group had significantly 
fewer crisis contacts over 3 months trial period 
compared to TAU, and at post treatment 
showed significantly greater reduction in 
negative symptoms, fewer cases of depression 
and a significant  increase in mindfulness skills. 
Changes in mindfulness skills correlated 
positively with changes in depression.  
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Study Type participants (n)  Age 
(mean 
years)
  
Gender  
(male %) 
Treatment 
group  
(n = 
total/after 
attrition) 
 
Comparis
on 
group(s) 
(n = 
total/after 
attrition) 
 
Attrition  
(Total % / 
treatment 
group %) 
Number 
of 
sessions 
Follow-
up 
(months) 
Outcome 
measures 
Results 
(AAQ II)  
Kentucky 
Inventory of 
Mindfulness Skills 
(KIMS) 
Working Alliance 
Inventory (Short 
Form Revised; 
WAI-SR)  
 
 
ACT = Acceptance and Commitment Therapy; ABCT = Acceptance-based cognitive-behavioural therapy; BDG = Dialectical Behaviour therapy-based psychoeducational group; CFT = 
Compassion-focused therapy; CP = conventional psychoeducation programme; ETAU = enhanced treatment as usual; MBCT = Mindfulness-based cognitive therapy; MBPP = 
Mindfulness-based psychoeducation programme; MT = Mindfulness training; TAU = treatment as usual; WL = Waiting list.  
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Five of the included studies were feasibility trials (Braehler et al., 2012; Chadwick et 
al, 2009; Chien & Lee, 2013; Gaudiano & Herbert, 2006; Langer et al., 2011), three 
were pilot studies (Bach & Hayes, 2002; Van Dijk et al., 2013; White et al., 2011) 
and three were full scale trials (Chien & Thompson, 2014; Perich et al, 2013; 
Shawyer et al., 2012). Six studies (Bach & Hayes, 2002/ Bach et al., 2012; Chien & 
Lee, 2013; Chien & Thompson, 2014; Gaudiano & Herbert, 2006; Perich et al., 
2013; Shawyer et al., 2012) used a follow-up design (between 4 to 24 months), while 
five did not. Four studies explored the use of an acceptance-based therapeutic 
approach (Bach & Hayes, 2002/Bach et al., 2012; Gaudiano & Herbert, 2006; 
Shawyer et al., 2012; White et al., 2011), five studies that of a mindfulness-based 
approach (Chadwick et al, 2009; Chien & Lee, 2013; Chien & Thompson, 2014; 
Langer et al., 2011; Perich et al., 2013), one study that of a compassion-focused 
approach (Braehler et al., 2012) and one study looked at a dialectical behaviour 
therapeutic intervention (Van Dijk et al., 2013). Seven of the interventions were 
delivered in group format (Braehler,  et al., 2013; Chadwick,  et al.,  2009; Chien & 
Lee, 2013; Chien & Thompson, 2014; Langer et al., 2011; Perich et al., 2013; Van 
Dijk et al., 2013), while four consisted of individual one-to-one sessions (Bach & 
Hayes, 2002; Gaudiano & Herbert, 2006; Shawyer et al., 2012; White et al., 2011).  
 
Dimensions of outcome  
 The impact of the mindfulness-based approaches on outcomes for people 
with psychosis-spectrum disorders was investigated based on areas of outcomes 
explored in the included studies (General clinical improvement, Psychiatric symptom 
changes, Rehospitalisation/crisis contacts, Depression and Anxiety, Social 
functioning and Quality of life, Positive and Negative Affect, Processes and 
mechanisms of change). 
 
General clinical improvement 
 Measures of general clinical improvement were used by three studies 
(Braehler et al., 2012; Chadwick et al., 2009; Gaudiano & Herbert, 2006) to assess 
the impact of the treatment condition. Two studies used the Clinical Global 
Impression-Improvement Scale (CGI-I) (Braehler et al., 2012; Gaudiano & Herbert; 
2006) for this purpose. Braehler et al. (2012) found a significant change in terms of 
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general clinical improvement in favour of the CFT treatment group, with 65% of the 
participants being rated as having improved compared to TAU (5%) at post-
intervention (p< 0.001, r=-0.68).  Gaudiano & Herbert (2006) however did not find a 
significant group difference in people with schizophrenia when considering pre and 
post mindfulness intervention scores versus waitlist. In Chadwick et al.’s (2009) 
study, scores on the Clinical Outcomes in Routine Evaluation (CORE) indicated 
significant improvement in clinical functioning in people with schizophrenia when 
considering pre and post mindfulness intervention scores (p<.013), however, no 
significant group effect was found when comparing to waitlist control.   
 
Psychiatric symptom changes  
 Changes in general psychiatric symptom severity was considered as an 
outcome by four studies, comparing treatment conditions to controls. Three of these 
studies (Chien & Lee, 2013; Chien & Thompson, 2014; Gaudiano & Herbert, 2006) 
used the Brief Psychiatric Rating Scale (BPRS). Chien & Lee’s (2013) study 
indicated a significant improvement of general psychiatric symptom severity for 
people with schizophrenia receiving Mindfulness-based psychoeducation program 
(MBPP), found at post-treatment as well as at 18-month follow-up. Chien & 
Thompson (2014) found an effect in favour of MBPP over Conventional 
psychoeducation programme (CPEP) and Usual care (F=4.36, P = 0.005). The BPRS 
score of the MBPP group increased more significantly from Times 1 to 4 (MBPP v. 
CPEP group, mean differences were 4.1, 6.7 and 11.1 (s.e.=0.9–3.0) and MBPP v. 
usual care group, mean differences were 6.1, 13.9 and 18.8 (s.e.=1.9–4.5) at Times 
2–4, respectively). Gaudiano & Herbert (2006) did not find a significant difference 
on the BPRS total score between groups attending the ACT intervention or receiving 
ETAU only.  
 A number of studies considered change in psychiatric symptoms more 
specific to psychotic symptom severity. One study (Langer et al., 2011), using the 
Clinical Global Impression-Schizophrenia Scale (CGI-SCH), did not find significant 
differences between MBCT group and waitlist controls. Two studies used the 
Positive and Negative Syndrome Scale (PANSS) (Shawyer et al., 2012; White et al., 
2011). While Shawyer et al (2012) did not find any significant group differences in 
PANSS scores between Acceptance-based cognitive therapy (ABCT) and 
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Befriending in people with schizophrenia-spectrum disorders, within-group analyses 
indicated significant improvements of PANSS total scores at post-treatment and at 6 
months follow-up in favour of the treatment group. In White et al.’s (2011) study, 
there was no significant difference between the groups with regards to positive 
symptoms at the end of treatment, but a significant reduction in negative symptoms 
was found in the ACT attenders (t=-2.36, df = 19, p <0.05). Three studies 
specifically considered changes in positive psychotic symptoms (Chadwick et al., 
2009; Gaudiano & Herbert, 2006; Shawyer et al., 2012). The Psychotic Symptom 
Rating Scales (PSYRATS) were used by two studies for this purpose (Chadwick et 
al., 2009; Shawyer et al., 2012). Attendance of Mindfulness training did not result in 
significant improvements of positive symptoms at the end of treatment in Chadwick 
et al’s (2009) study when compared to waitlist controls and when within-group 
changes were considered. Shawyer et al. (2012) used the auditory hallucination 
subscales of the PSYRATS only and also did not find significant group differences 
between ABCT and Befriending group. Both of these studies also used the Beliefs 
about voices questionnaire revised (BAVQ-R), but neither found a significant change 
in psychotic symptoms and beliefs about voices after Mindfulness training or ABCT 
when comparing to controls. Two studies (Bach & Hayes, 2002; Gaudiano & 
Herbert, 2006) used Self-ratings of psychotic symptoms to evaluate change in 
frequency of positive symptoms, change in distress related to and believability of 
them over time. In Bach & Hayes (2002), symptom reporting was higher in ACT 
participants (p< .016) at 4 months follow up, but believability of symptoms 
decreased significantly compared to controls, F(1,29) = 4.36, p = .05. Distress 
related to symptoms also decreased however this was not significant when compared 
to TAU. In Gaudiano & Herbert (2006), significant improvement of distress related 
to symptoms was found in people attending individual ACT sessions compared to 
ETAU participants (F1;26 =4:62, p<0.05), however hallucination frequency or 
believability were not affected significantly in this group. Within the ACT attenders 
a significant main time effect of decrease in believability of hallucinations was found 
(F1; 13 =5:56, p<0.05) and further analysis indicated that change in hallucination 
believability was an independent predictor of change in distress after controlling for 
change in frequency. Perich et al (2013) investigating the impact of MBCT on 
severity and time to recurrence of bipolar symptoms used the Young Mania Rating 
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Scale (YMRS) over various time-points to assess changes specific to hypo/manic 
episodes. No significant difference between MBCT and TAU conditions was found 
with regards to severity or recurrence of manic symptoms. 
 
Rehospitalisation/crisis contacts 
 Four studies considered rehospitalisation as an outcome when measuring 
impact of mindfulness-based interventions (Bach & Hayes 2002/Bach et al 2012; 
Chien & Lee 2013; Chien & Thompson, 2014; Gaudiano & Herbert, 2006), while 
one study looked at number of crisis contacts during treatment (White et al (2011). 
In Bach & Hayes (2002), ACT participants had a significantly lower rate of 
rehospitalisation during 4 months follow-up compared to TAU (Wilcoxon’s statistic: 
(1, N = 70) = 4.26 p < .05), and remained out of hospital significantly longer than 
TAU (F(1,60) = 4.74, p= .03). This benefit was maintained at 12 months (Bach et al., 
2012). Chien & Lee (2013) also found a significant change with regards to number 
(p<.01) and duration (p<.001) of hospitalisation, however this was only apparent at 
18 months follow-up. Chien & Thompson (2014) did not find an effect on number of 
readmissions for MBPP compared to conventional psychoeducation programme 
(CPEP) and usual care. However, MBPP was associated with reduced duration of 
admissions. The duration of readmissions to hospital in the MBPP group were 
significantly reduced from Times 1 to 4 (F=4.8, p = 0.004), (MBPP v. CPEP group, 
mean differences (days) were 0.5, 3.5 and 5.1 (s.e. = 0.2–1.8) and MBPP v. usual 
care group, mean differences were 4.1, 7.2 and 10.0 (s.e.=1.2–4.9) at Times 2–4, 
respectively). In Gaudiano & Herbert (2006) rehospitalisation rates were  lower in 
the ACT group at 4 months follow-up (28% of ACT compared to 45% of ETAU), 
however this was not significant. White et al (2011) compared number of crisis 
contacts of participants receiving ACT or TAU and found that the ACT group had 
significantly lower number of crisis contacts for the duration of treatment (Z = -2.24, 
p < 0.05).  
 
Depression and Anxiety 
 Levels of depressive symptoms were considered as a primary outcome by 
three studies (Van Dijk et al., 2013; Perich et al., 2013; White et al., 2011). The Beck 
Depression Inventory II (BDI II) was used by Van Dijk et al. (2013) as an outcome 
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measure, with the results indicating a significant reduction in depression severity 
between DBT-group participants with bipolar disorder and waitlist controls (χ² = 
6.75, p = .0009). However, when baseline differences in depression were controlled 
for significance dissipated, though a trend in favour of the treatment group remained. 
Perich et al (2013) did not find a significant difference between participants with 
bipolar disorder attending either a MBCT group or receiving TAU with regards to 
levels of depression, anxiety, and stress as measured by the Depression Anxiety 
Stress Scales (DASS) at post-treatment and at up to 12 months follow up. However a 
trend was noted on the stress subscale for treatment by time in favour of MBCT 
group (F = 1.864, P = 0.088).  This study also used the Dysfunctional Attitudes Scale 
24 (DAS-24) and the Response Style Questionnaire (RSQ). MBCT participants 
showed a significant improvement over time on the achievement subscale of the 
DAS-24 (F = 2.534, p = 0.03), but not on the other subscales, while response style 
was not affected significantly, as assessed by comparing scores on the RSQ. In 
addition, Perich et al (2013) were interested in investigating the impact of MBCT on 
severity and time to recurrence of depression as part of bipolar disorder. 
Consideration of scores on Montgomery-A˚sberg Depression Rating Scale (MADRS) 
over various time-points did not identify a significant difference between MBCT and 
TAU with regards to time to recurrence or number of recurrent depressive episodes. 
One study (White et al., 2011) used the Hospital Anxiety and Depression Scale 
(HADS) but did not find significant differences between people with psychosis-
spectrum disorders attending individual ACT sessions or receiving TAU with 
regards to changes in symptoms of either depression or anxiety at post-treatment. 
There was however a trend towards significance for depression with (t= -2.09, df = 
19, p = 0.051) in favour of the ACT group. Post-hoc analyses compared caseness of 
depression and anxiety pre and post-intervention and found that a significantly 
smaller number of individuals in the ACT group met caseness for depression post 
treatment (from 8 to 2 individuals) compared to TAU (likelihood ratio χ²=5.00, p 
<0.05). There was no significant difference in change in caseness for anxiety in any 
group.  
 Impact of treatment on anxiety symptoms was specifically explored by Perich 
et al. (2013) who used the anxiety section on the Composite International Diagnostic 
Interview (CIDI) to measure the presence of an anxiety disorder at baseline and at 12 
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months. No significant difference was found in people with bipolar disorders 
attending MBCT or receiving TAU with regards to whether or not diagnostic criteria 
for an anxiety disorder were met. Scores on the State/Trait Anxiety Inventory (STAI) 
however pointed towards a significant reduction in state anxiety over time in people 
receiving MBCT when the groups were compared. 
  
Social functioning and Quality of life  
 Change in general functioning and/or quality of life following intervention 
were explored by four studies (Chien & Lee, 2013; Chien & Thompson, 2014; 
Gaudiano & Herbert; 2006; Shawyer et al., 2012). Chien & Lee (2013) and Chien & 
Thompson (2014) used the Specific Level of Functioning Scale (SLOF) and the 
Social Support Questionnaire (SSQ-6). In Chien & Lee (2013) scores on the SLOF 
indicated a significant change following MBPP with regards to general functioning 
apparent at 18 months follow-up, but there were no significant group differences 
with regards to levels of social support available (SSQ-6). Chien & Thompson 
(2014) found that MBPP was associated with improved functioning (F=4.98. 
p=0.004) but not social support. Specifically, the MBPP group increased more 
significantly from Times 1 to 4 (MBPP v. CPEP group, mean differences were 12.0, 
22.7 and 30.8 (s.e. = 3.0–4.9) and MBPP v. usual care group, mean differences were 
26.2, 47.3 and 57.8 (s.e. = 4.8–7.6) at Times 2–4, respectively). Gaudiano & Herbert 
(2006), using the Sheehan Disability Scale (SDS), found significant differences on 
the social subscale (F1;26 =9.09, p<0.01) in favour of ACT, but there were no 
significant differences on work or family subscales. One study (Shawyer et al., 
2012), using the Modified Global Assessment of Functioning scale (Modified GAF), 
found significant improvements of general functioning in people with schizophrenia-
spectrum disorders following ACT at 6 months follow-up (p<.05). However, 
between-group scores on the Quality of Life Enjoyment and Satisfaction 
Questionnaire (Feelings and General Activities subscales) were not significant.  
 
Positive and Negative Affect 
 Two studies considered changes in affect as an outcome (Braehler et al., 
2012; Van Dijk et al (2013). Braehler et al. (2013), using the Positive and Negative 
Affect Scale (PANAS), did not find any significant changes when comparing scores 
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on this measure between groups as well as within. Van Dijk et al (2013) were 
interested in the impact of DBT-based intervention on affective control in people 
with bipolar disorder using the Affective control scale (ACS), but did not find a 
significant treatment effect in terms of affective control between DBT intervention 
group and waitlist controls. However, scores improved in both groups over time. 
 
Processes and mechanisms of change 
 Mindfulness. Four studies specifically looked at changes in mindfulness in 
response to treatment (Chadwick et al., 2009; Perich et al., 2013; Van Dijk et al., 
2013; White et al., 2011). Chadwick et al (2009) used the Southampton Mindfulness 
Questionnaire (SMQ) and found that attendance of the mindfulness group 
intervention led to significant improvement in mindfulness of distressing thoughts 
and images in people with schizophrenia having distressing psychotic experiences 
(p<.037), as assessed at endpoint. However, this was not significant at group 
comparison level. This study also used the Southampton Mindfulness Voices 
Questionnaire (SMVQ). Results on this measure were non-significant, both at group 
and group comparison level. Attendance at MBCT group intervention in Perich et al. 
(2013) did not result in significant changes in trait mindfulness as assessed by the 
Mindful Attention Awareness Scale (MAAS). In Van Dijk et al. (2013) comparison of 
total scores of the Mindfulness-based self-efficacy scale (MSES) did not show 
significant differences between people in the DBT-based psychoeducation group or 
waitlist group with regards to improved perception of mindfulness self-efficacy. 
However, total scores increased more for the intervention group (interaction x group 
F=9.41, p=.006), particularly in the subscales of Interpersonal, Avoidance and 
Mindfulness. White et al (2011) used the Kentucky Inventory of Mindfulness Skills 
(KIMS) to explore therapy-specific changes and associations between change scores 
in general outcome and therapy-specific effects and found a significant difference in 
scores between people attending ACT and receiving TAU (t= 2.66, df =21, p <0.05). 
Results also showed significant relationships between the depression subscale of the 
HADS and change scores for the KIMS Total score (r=-0.66, p <0.05), andKIMS 
subscales of Describing (r=-0.70, p <0.05) and Acting with awareness (r=-0.72, p 
<0.01). 
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 Compassion. One study (Braehler et al., 2012) investigated therapeutic 
changes specific to CFT in terms of its impact on compassion and avoidance using 
the Narrative Recovery Style Scale (NRSS). They also explored associations between 
those constructs and a number of clinical outcomes post-intervention by considering 
scores on the NRSS and BDI II, Personal Beliefs about Illness Questionnaire 
(PBIQ-R), and Fear of Recurrence Scale (FoRSe). Overall, CFT participants showed 
significantly more compassion in their narratives compared with TAU participants 
(U = 75, Z = -2.43, p = 0.015, r = -0.42), with a significant increase in compassion (r 
= 0.59; Z =-2.36, p = 0.02). Reduction in avoidance was moderate (r = 0.41) but not 
significant. In the CFT group, an increase in compassion was significantly associated 
with reductions in BDI depression (r = -0.77; p = 0.001), PBIQ entrapment (r = 0.56; 
p = 0.031), PBIQ shame (r = 0.57; p = 0.027), PBIQ social marginalization (r = 0.74; 
p = 0.002), FoRSe intrusive thoughts (r = 0.58; p = 0.022), and FoRSe fear of relapse 
(r = 0.52; p = 0.045). 
 Psychological flexibility. Two studies used the Acceptance and Action 
Questionnaire II (AAQ II) to compare changes in psychological flexibility between 
treatment groups (White et al., 2011; Langer et al., 2011). Neither of these studies 
found a significant difference between the groups with regards to acceptance and 
experiential avoidance. Shawyer et al (2012) used the Voices Acceptance and Action 
Scale (VAAS) to assess change in acceptance-based attitudes and actions associated 
with auditory hallucinations but no significant differences between groups were 
found. They also explored the impact of ABCT with regards to level of involvement 
with auditory command hallucinations and beliefs about the omnipotence of voices 
as measured by subscales on the SHER and BAVQ-R. No significant differences 
between the groups were found. The same was true for changes in recovery style as 
assessed by Recovery Style Questionnaire (RSQ).  
 Insight. Given that core components of mindfulness-based approaches are to 
increase awareness and develop cognitive flexibility to enhance recovery, increase of 
illness awareness (i.e. illness insight) could be seen as an outcome associated with 
intervention process changes. It is therefore summarized under this heading. Three 
studies looked at changes in illness insight (Chien & Lee 2013; Chien & Thompson, 
2014; Shawyer et al., 2012). Chien & Lee (2013) and Chien & Thompson (2014) 
both used the Insight and Treatment Attitudes Questionnaire (ITAQ). Chien & Lee 
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(2013) found a significant change in terms of insight in people with schizophrenia at 
post-treatment compared to TAU (p<.001). Chien & Thompson (2014) also found an 
overall effect in favour of MBPP (F=6.52, p = 0.001).The ITAQ score of the MBPP 
group increased more significantly from Times 1 to 4 than in the other two groups 
(MBPP v. CP group, mean differences were 0.7, 3.0 and 5.0 (s.e. = 0.3–1.9) and 
MBPP v. usual care group, mean differences were 1.7, 4.9 and 6.5 (s.e. = 0.6–2.4) at 
Times 2–4, respectively). Shawyer et al (2012) however did not find any significant 
difference between people attending ACT or Befriending with regards to insight, 
using an Insight Scale, however, insight appeared to improve significantly for the 
experimental group following ACT (p<.05 for experimental group).  
 
Risk of bias in included studies 
 A risk of bias assessment was undertaken for all included trials. Table 2 
provides an overview of the reviewers’ judgements about each risk of bias item for 
each included study. Appendix 1.5 provides an overview of how the judgements 
were reached. 
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Table 2 - illustrating author’s judgements about each risk of bias item for each 
included study 
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Bach & Hayes (2002); Bach et al (2012)  
 
        
Braehler et al. (2012) 
 
        
Chadwick et al. (2009) 
 
        
Chien & Lee (2013) 
 
        
Chien & Thompson (2014)  
 
        
Gaudiano & Herbert (2006) 
 
        
Langer et al. (2011) 
 
        
Perich et al (2013) 
 
        
Shawyer et al (2012) 
 
        
Van Dijk et al. (2013) 
 
        
White et al. (2011) 
 
        
 
Key:          = Low risk;      = Unclear risk;      = High risk 
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Allocation 
 All studies reported random assignment of participants to treatment 
conditions. However, only five studies (Braehler et al., 2013; Chien & Thompson, 
2014; Perich et al., 2013; Shawyer et al., 2012; White et al., 2011) provided details 
of the process used for this purpose and were rated as low risk of bias. The 
remaining six studies were judged to have unclear risk of bias due to insufficient 
description of the randomization process. With regards to allocation concealment, 
only five studies had a low risk of bias (Chien & Thompson, 2014; Perich et al., 
2013; Shawyer et al., 2012; Van Dijk, 2013; White et al., 2011), while the risk was 
unclear in five studies, failing to provide sufficient information. One study 
(Gaudiano & Herbert, 2006) was rated to have high risk of selection bias as 
allocation was not concealed. 
 
Blinding 
 None of the studies were double-blind due to the nature of these trials. While 
double-blinding is generally an important way to prevent bias, this, by default, is not 
possible in trials assessing the effectiveness of psychological therapeutic 
interventions such as the studies included in this review. It was therefore decided to 
rate all of the studies as having low risk of bias with regards to the performance bias 
criteria due to lack of relevance of this to the studies under review. Two studies were 
rated low risk with regards to detection bias as they went through considerable 
efforts to blind outcome assessors, formally assessed effectiveness of blinding and 
made attempts to rectify any breaches (Shawyer et al., 2012; White et al., 2011). 
Seven studies were rated as having unclear risk of detection bias, with two studies 
not providing any information about blinding of outcome assessors, while the 
remaining four described that process but did not give indication of whether the 
effectiveness of blinding attempts was assessed, nor how breaches were managed. 
The remaining two studies (Bach & Hayes, 2002/Bach et al., 2012; Gaudiano & 
Herbert, 2006) were judged to have high risk of detection bias as outcome assessors 
were not blind to allocation.  
  
Incomplete outcome data 
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 Seven studies had a low rate of attrition and were therefore deemed to have 
low risk of bias with regards to completeness of outcome data. However, two of 
these (Chien & Lee, 2013; White et al., 2011) failed to provide reasons for drop-outs. 
One study had an unclear risk of attrition bias (Van Dijk et al., 2012) as no 
information was provided, while the remaining three studies were rated as having 
high risk of bias in this area due to high attrition rates (>30%) (Braehler et al., 2012; 
Langer et al., 2011; Perich et al., 2013).  
 
Selective reporting 
 Risk of reporting bias was deemed low for five studies as no selective 
reporting apparent (Braehler et al., 2012; Perich et al., 2013; Shawyer et al., 2012; 
Van Dijk et al., 2013; White et al., 2011). Three studies were judged to have unclear 
risk of bias with regards to selective reporting. Two of these failed to provide 
sufficient detail with regards to explaining some of the reported results (Chadwick et 
al., 2009; Chien & Lee, 2013), while one study’s (Chien & Thompson, 2014) 
reporting of the results deviated from the description on the registered trial protocol.  
The remaining three studies (Bach & Hayes, 2002/Bach et al., 2012; Gaudiano & 
Herbert, 2006; Langer et al., 2011) omitted reporting of some of their outcomes or 
reported the results of post-hoc analyses selectively. These studies were therefore 
judged to have high risk of reporting bias.   
 
Other potential sources of bias 
 Three of the studies (Chien & Thompson, 2014; Perich et al., 2013; Shawyer 
et al., 2012) were judged to have low risk of bias with regards to other potential 
sources. The remaining eight studies were rated as high risk of bias due to small 
sample size, significant group differences at baseline, lack of clarity regarding 
sample selection/issues of pre-selection, variation of amount of treatment received, 
speculative interpretations of mechanism underlying results or lack of controlling for 
other variables (e.g. past treatment history or ongoing psychotherapy).   
 
Assessment of protocol registers 
 Four studies had registered their trial post-study on trial registers (Chien & 
Thompson, 2014; Perich et al., 2013; Shawyer et al., 2012; White et al., 2011). Two 
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of these deviated from their originally registered protocol on some aspects. In one 
study (White et al., 2011) there was a change in terms of exclusion criteria between 
protocol and published report, while in the other sample size was smaller than the 
one originally aimed for (Perich et al., 2013). Neither of these deviations was 
deemed as significantly introducing bias impacting on outcome of trials.  
 
Overall risk 
 Based on the above assessment, the majority of studies were judged to have a 
high risk of bias overall. Only three studies were deemed low risk of bias (Chien & 
Thompson, 2014; Shawyer et al., 2012; White et al., 2011).  
 
 
DISCUSSION 
 
Summary 
 The aim of this review was to identify, summarize and appraise RCTs of 
mindfulness-based therapeutic approaches in the treatment of psychosis-spectrum 
disorders in order to further understanding of the existing evidence-base of these 
approaches for use with this population, building on previous reviews (e.g. Khoury 
et al., 2013). Khoury et al.’s (2013) meta-analysis indicated a moderate effectiveness 
of mindfulness-based interventions in treating negative symptoms and suggested 
their use combined with pharmaceutical treatment. However, the review included 
uncontrolled and non-randomized studies and did not undertake a rigorous 
assessment of risk of bias of the included studies.  The current review aimed to 
address these limitations by including RCTs only and assessing risk of bias more 
rigorously by using the Cochrane risk of bias tool (Higgins et al., 2011a).  The 
current review identified 11 studies (based on 12 manuscripts) in an extensive 
literature search, comprising a total sample of 599 inpatients and outpatients with 
psychosis-spectrum disorders. Similar to Khoury et al.’s (2013) review, there was 
considerable heterogeneity between the included studies with regards to areas such 
as type and format of mindfulness-based approach used (e.g. group or individual) 
and length of intervention (ranging between 4 to 16 sessions), as well as significant 
variation in terms of assessed outcome/type of outcome measures used and quality of 
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included studies. In light of this, it was felt more meaningful to examine the studies 
individually and then synthesise their findings in descriptive format as opposed to 
combining them by use of statistical method. As such, overall conclusions on the 
basis of combined results could not be made. Individual studies found some 
significant results and positive trends in favour of the treatment conditions compared 
to controls, suggesting potential benefits of mindfulness-based interventions with 
regards to e.g. reduction and duration of rehospitalisation, change in general 
symptom severity and functioning, trends towards reduction in depressive 
symptomatology and some links between increased compassion and/or 
psychological flexibility and reduced depression. However, the majority of results of 
between-group comparisons were non-significant. More importantly, risk of bias 
within individual studies was high. Only three studies were judged low in terms of 
risk of bias, while the rest were deemed to have an overall high risk of bias. For the 
majority of these studies issues of bias particularly relevant to the overall validity of 
estimated treatment effect were identified in the areas of detection bias (blinding 
outcome assessors) and other sources of bias (mainly small sample size, 
interpretation of results, group differences at baseline, and unclear pre-selection 
processes). As such, it is difficult to make concrete judgements about the 
effectiveness or draw clear conclusions with regards to benefits of mindfulness-
based approaches for people with psychotic-spectrum disorders based on these 
studies. It is of note that studies with low risk of bias did not find significantly greater 
treatment effects. In fact, two of the three studies with an overall low risk of bias did 
not yield significant results, while the third one was moderate in their treatment 
effectiveness. However, it needs to be considered that the majority of the included 
studies were either feasibility or pilot studies and as such sample sizes were small.  It 
may be that treatment effects would have been more significant with larger samples.  
 
Limitations  
 This review has a number of limitations. Firstly, it did not include 
unpublished studies (grey literature) as such the possibility of publication bias may 
have to be considered. However, given that the current review did not allow for 
overall conclusions about treatment effectiveness this may not be as significant. 
Furthermore, judgement of risk of bias of included studies was, in most cases, based 
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on the assessment of two reviewers. While this allowed for a degree of inter-rater 
reliability, it could be argued that more independent raters could have been consulted 
to reduce potential risk of reviewer bias. However, given time limitations this was 
difficult to achieve. As indicated, the included studies had a high level of 
heterogeneity. While this limited the scope for a more rigorous analysis, it reflects 
the current state of the literature in the field. Lastly, while the reviewer undertook an 
extensive search of the literature, there still may be studies that were missed.  
 
Conclusions 
 As outlined above, the heterogeneity and particularly high risk of bias in 
RCTs assessing the use of mindfulness-based interventions in psychosis-spectrum 
disorders does not allow for concrete judgements about the effectiveness of these 
approaches. As such, the outcome of the current review does not indicate a 
superiority over or equality with other evidence-based treatments for psychosis-
spectrum disorders, such as CBTp at this point in time. Recommendations regarding 
the routine use or incorporation of these treatments into best practice guidelines are 
therefore premature. However, given potential benefits indicated by the studies and 
the absence of adverse effects associated with their use with a psychosis population, 
they should be available as a choice to people with psychosis-spectrum disorders.  
Clearly, more rigorous studies, addressing important areas of bias such as using 
larger sample sizes and more consistency in the application and format of different 
mindfulness-based interventions are needed to build on the existing evidence-base 
and gain greater insight into the mechanisms underlying them.  
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TITLE 
 
Constructing shared understanding - A grounded theory exploration of team case 
formulation from multiple perspectives  
 
 
ABSTRACT 
 
Objectives: The use of formulation in teams is becoming increasingly established. 
Yet, research into this area is still limited. This study set out to explore team 
formulation from multiple perspectives in the context of an early intervention first 
episode psychosis service. 
Method: A social constructionist version of grounded theory was used to explore 
experiences of team formulation and care of fifteen participants (clinical 
psychologists, other multidisciplinary team members, and service-users), using semi-
structured interviews. A phased approach to data collection and analysis facilitated 
theoretical sampling and triangulation. Transcripts were subjected to line-by-line and 
focused coding to support the development of categories grounded in the data.  
Results: An emerging model of team formulation arose from the data, comprised of 
two levels - ‘value and function’ and ‘processes’ - that were interrelated and made up 
of sub-themes. ‘Value and function’ of team formulation ultimately was to improve 
engagement and care for service-users at risk of arrested recovery. This was seen to 
be facilitated by ‘constructing understanding’ and ‘broadening perspectives’, 
resulting in ‘flexibility, consistency and empathy’ that allowed for person-centred 
care planning and the establishment of better relationships with service-users. Team 
formulation involved and required staff to ‘negotiate roles’ and ‘manage 
uncertainty’. The data indicated the importance of a system or space that promotes 
the development of mutuality of meaning and shared understanding.  
Conclusions: This study indicated the systemic value of team formulation in 
supporting people who have difficulties engaging with services and staff working 
with them. The emerging model derived provides a meaningful departure point to 
develop a more comprehensive theory of team formulation that could provide a 
foundation for improving, developing and disseminating this practice. 
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INTRODUCTION 
 
 Case formulation has been recognized as central to the implementation of 
psychological interventions since the emergence of the scientist-practitioner model 
in the 1960s (Butler, 1998). It is an approach increasingly valued by professionals 
within psychiatry, psychology, psychotherapy and counselling. Definitions of 
formulation can vary depending on professional background and therapeutic 
approach. It can be summarized as “[ ] a hypothesis about a person’s difficulties, 
which draws from psychological theory” (Johnstone & Dallos, 2014, p. 5). The 
Division of Clinical Psychology (DCP) (2010, p. 5) describes it as “[ ] the 
summation and integration of the knowledge that is acquired by the assessment 
process that may involve psychological, biological and systemic factors and 
procedures”. Integrating empirical evidence and theory, it constitutes a hypothesis 
about the causes, triggers and perpetuators influencing someone’s psychological, 
interpersonal and behavioural problems (Eells, 2006b). It is proposed that the 
understanding derived may then facilitate a more tailored, individualized approach to 
care as opposed to a standardized one based on diagnostic categories (Aston, 2009). 
Furthermore, it may help predict potential barriers and challenges to intervention, for 
example by facilitating understanding of service-users’ ability to build and maintain 
therapeutic alliances and engage with services (Sturmey, 2009).  In practice, 
formulation is seen as an on-going process that arises from assessment and 
collaboration with service-users and teams (Johnstone & Dallos, 2014). 
Reflectiveness is important to ensure that the developing formulation is a meaningful 
account of service-user’s difficulties (DCP, 2011). Various professional bodies have 
identified psychological case formulation as a core professional competency for 
clinical psychologists, e.g. Health Professions Council (HPC) (2009) and British 
Psychological Society (BPS) (2010).  
 Increasingly, formulation is used in multidisciplinary teams (MDT), both in 
the community and inpatient settings. Team formulation refers to the process of 
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constructing a shared understanding of an individual’s difficulties and resources for 
effective change within a group or team (Johnstone & Dallos, 2014). It has been 
argued that it can lead to a more holistic and psychosocial understanding of a 
service-user by incorporating views and ideas from different disciplines, which may 
then facilitate a more consistent and person-centred approach to intervention 
promoting recovery (Onyett, 2007). Professional practice guidelines, e.g. Good 
Practice Guidelines on the use of psychological formulation (DCP, 2011) and Health 
& Care Professions Council criteria (HPC, 2009), recommend a formulation-based 
approach to be taken in teams, with clinical psychologists having an active role in 
promoting and facilitating this. 
 According to Johnstone (2014), important properties of team-based 
formulation include availability of specifically allocated time, presence and 
contributions of all MDT members, and space that allows the team to think freely 
and creatively, drawing on their own clinical experience, knowledge and intuition. It 
is seen to be a space in which members of staff are able to reflect on their struggles 
with a particular service-user and explore their emotional responses, including issues 
of transference and counter-transference. Team formulation may therefore be of 
particular value for teams working with people with complex needs whose 
interpersonal and relational style and response to care may be experienced as 
challenging by staff and at odds with attempts to support them in their recovery.  For 
example, insecure attachment styles, particularly avoidant/dismissive type, have 
been found to be more common in people with psychosis, impacting on their ability 
to form relationships that allow them to express their needs and seek help effectively 
(Tait, Birchwood & Trower, 2004). Instead, they may engage in avoidant coping, 
such as ‘sealing over’, complicating their engagement with services, treatment and 
ultimately recovery. This can heighten staff levels of stress and frustration, which 
may impact on their response to the person, for example leading to more coercive 
treatments (Thornicroft et al., 2013). Therefore, team formulation may be invaluable 
to staff working with difficult to engage service-users, helping to make sense of 
behaviours and responses in order to better support them. For example, 
understanding an individual’s attachment style and the implications of that with 
regards to forming relationships and help-seeking may allow teams to understand 
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their struggles better and become more flexible and person-centred in their response, 
hence prevent disengagement and better support recovery (Gumley et al., 2010). 
 Despite increasing emphasis placed on using formulation in teams the 
research evidence-base is still limited (Johnstone & Dallos, 2014). A small number 
of qualitative studies, service evaluations and audits have explored its use and 
indicate potential benefits as well as challenges related to team formulation. In a 
qualitative study, Summers (2006) interviewed twenty-five staff of different 
disciplines (including psychiatrists, nurses, support workers and therapists), working 
in a team providing care for people with severe mental illness on a ward of a high-
dependency rehabilitation service. Staff viewed formulations as valuable to gain a 
better understanding of service-users, which was seen to lead to better care planning, 
staff-service-user relationships, staff satisfaction and team working. There was some 
dissatisfaction with a lack of translating the derived understanding into practice 
consistently. However, staff felt that they had become more tolerant and able to 
respond with patience and empathy towards service-users; a finding which was 
supported by Wainwright & Bergin (2010).  In another qualitative study, 
Christofides et al. (2011) interviewed ten clinical psychologists working in an adult 
inpatient setting about their experiences of using formulation within MDT and found 
similar results. Clinical psychologists felt that shared formulation facilitated a 
broader and more consistent understanding of service-users in the team, and 
promoted reflectiveness in staff. Psychologists did however express some 
uncertainty with regards to clearly defining their role when supporting formulation 
more informally. In a follow-up study by Hood et al. (2013) non-psychology staff 
members equally expressed positive experiences of team formulation, valuing it for 
increasing their understanding of service-users and their behaviours. Non-
psychologist MDT staff interviewed in Dexter-Smith et al. (2010) highlighted the 
value of team formulation with regards to combining perspectives from different 
professional backgrounds. In addition to benefits outlined above, this was felt to help 
emotional containment of staff working in stressful environments. Another 
evaluation indicated possible benefits with regards to reduction in staff sickness 
(Down, 2010). Consistently, time constraints were identified as a major barrier to 
implementing team formulation. An interesting finding in Summers (2006) related to 
differences in staff views about the nature of the derived understanding being ‘fact’ 
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and therefore formulation leading to clear management solutions versus ‘provisional 
hypotheses’ with the formulation giving room to speculate and discuss ideas.  
 Overall, these studies offer valuable insight into staff experiences of using 
formulation within MDT, highlighting benefits and challenges. However, 
consistency is lacking between them in how team formulation was implemented, 
ranging from informal to formal methods. This makes it difficult to draw overall 
conclusions about the utility of team formulation more generally and to identify 
more general principles underlying this process.  Furthermore, these studies explored 
team formulation from one particular point of view only, either that of staff more 
generally, or clinical psychologists more specifically. Yet, formulation is based on 
communication and interaction between different members of staff, service-users 
and, where relevant, family members/carers, developing dynamically within the 
discourse taking place between these individuals. It is therefore likely that the 
process of formulation may be experienced differently from different perspectives. 
Additionally, formulation is suggested to have the potential to improve service-
users’ experience of care, facilitating recovery. Exploring team formulation from 
only one perspective makes it difficult to fully grasp the complexity and benefits of 
this process overall, and to understand its value for the people involved in it 
individually. It appears that a comprehensive exploration of the process of team 
formulation requires the use of a methodological approach that actively promotes 
triangulation, thus allowing for the exploration of the perspectives of everyone 
involved in the process in a dynamic and flexible way.  
 
Point of departure  
 As outlined above, service engagement and engagement with staff is central 
to recovery (Tait, Birchwood & Trower, 2004). Team formulation may be an 
important tool to facilitate that. The point of departure for the current study therefore 
was to explore experiences of team formulation in a team where this is a central part 
of routine clinical practice, particularly for service-users that have difficulties 
engaging with the service. Given the collaborative nature of team formulation, 
multiple perspectives including those of clinical psychologists, other mental health 
staff and service-users were explored. As clinical psychologists’ take an active role 
in facilitating team formulation this was the most logical departure point. From there, 
  
 
45 
 
a stepped approach to qualitative enquiry was taken, allowing for the involvement of 
other staff members and service-users in a top-down, but dynamic and flexible 
fashion.  
 
Service context 
 The study was set in the context of an early intervention (EI) first episode 
psychosis service in Glasgow. Working with this complex client group, team 
formulation is a firmly established routine practice as part of weekly MDT meetings 
within this service. As indicated above, insecure attachment style has been found to 
be more prevalent in this client group and has been linked to poorer outcome due to 
its impact on coping style (e.g. sealing over) and service engagement (Gumley et al., 
2014). Service engagement here refers to level of adherence, collaboration and help-
seeking, which has been found to be poorer in people with psychosis and insecure 
attachments (Tait, Birchwood & Trower, 2004). Bearing these developmental and 
interpersonal complexities in mind, the task of establishing and maintaining 
supportive and collaborative working relationships and providing appropriate 
biopsychosocially informed care to service-users can be challenging for staff 
working in this service. It may trigger feelings of professional ineffectiveness and 
frustrations that can make it difficult to maintain a compassionate stance. More 
importantly, failure to respond in a way that facilitates service engagement can 
significantly reduce the potential for recovery for service-users to whom this is 
challenging (Gumley et al., 2014).  As such, the service has adopted the routine use 
of the Service engagement scale (SES) (Tait, Birchwood & Trower, 2002) in order to 
identify service-users at risk of arrested recovery. A high score on this scale prompts 
an additional reformulation meeting, aiming to increase the team’s understanding of 
barriers to recovery for that individual and highlighting alternatives to responding.   
 
 
METHOD 
 
Grounded theory methodology 
 Grounded Theory (GT) is a qualitative method widely used. It may be 
defined as “the discovery of theory from data systematically obtained from social 
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research” (Glaser & Strauss, 1967, p. 2), a way to learn about the “worlds we study 
and a method for developing theories to understand them” (Charmaz, 2006). Given 
the subject of study, a social constructionist version of GT (Charmaz, 2006) was 
used. This version has its roots in ‘social interactionism’ (Mead, 1934), which 
assumes that the meanings people give to situations determine human behaviour. 
These meanings are influenced by history, culture and language, and actively 
constructed within social interactions, mediated by an interpretive process used by 
each person. Hence, meaning is to be viewed as a constructed process. As a result, 
GT arises from the interaction between researcher and participants – it is actively 
constructed, rather than representing an objective reality. In this way, reflexivity with 
regards to the researcher’s and participants’ interpretations is actively promoted and 
an integral part of making sense of the data. To increase methodological rigour, 
credibility and utility, criteria for improving the quality of qualitative research (e.g. 
data triangulation) have been considered in the design and implementation of the 
qualitative study (Guion, 2002; Golafshani, 2003; Walsh & Downe, 2006).  
 
Participants 
 Participants were purposively sampled and included five clinical 
psychologists, four non-psychologist staff members, and six service-users. Eight of 
the participants were male and seven female, with age ranging from 24 – 54 (Table 
1). Given the research approach, sample size did not need to be determined. Rather, 
data collection continued until sufficiency was deemed to be reached. All 
participants were recruited from an EI first episode psychosis service in Glasgow 
that comprises three teams. All of the staff members who had agreed to take part in 
the study participated in the interview. Of the nine service-users who agreed to take 
part, three did not. One experienced deterioration in mental state and was therefore 
unable to take part in the study, while the other two decided subsequently that they 
did not wish to participate, without stating reasons.  
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Table 1: Participant details 
 
 Gender Role 
Participant 1 Male Clinical psychologist 
Participant 2 Female Clinical psychologist 
Participant 3 Male Clinical psychologist 
Participant 4 Male Clinical psychologist 
Participant 5 Female Clinical psychologist 
Participant 6 Female Community psychiatric nurse 
Participant 7 Female Occupational therapist 
Participant 8 Female Support worker 
Participant 9 Male Community psychiatric nurse 
Participant 10 Male Service-user 
Participant 11 Female Service-user 
Participant 12 Male Service-user 
Participant 13 Female Service-user 
Participant 14 Male Service-user 
Participant 15 Male Service-user 
 
 
Procedures  
 Recruitment of staff involved the introduction of the researcher and provision 
of brief information about the study to the MDT at a team meeting. This was 
followed by emailing or approaching staff in person, providing more detailed 
information about the study. They were given time to consider participation before 
being asked to take part. All of the service-user participants approached had been 
rated on the SES as having difficulties engaging with the service, hence being at risk 
of arrested recovery (as outlined above). They had already consented to participate in 
this qualitative evaluation as part of a wider CSO funded study of implementation of 
a novel Integrated Care Pathway for early psychosis (CZH/3/5, Compassionate 
Recovery: Individualised Support in early Psychosis (CR:ISP) implementing 
improvement strategies based on an Integrated Care Pathway for Early Psychosis), 
which had been granted ethical approval (11/AL/0247; Appendix 2.2). Prior to 
approaching these participants, it was checked that they were able to take part by 
seeking out the opinions of key staff members involved in their care. They were then 
contacted via telephone by a research assistant familiar to them and invited to take 
  
 
48 
 
part. Inclusion criteria required that all participants were involved with the EI 
service, and able to consent to and participate in the study. All participants gave 
informed consent (see Appendices 2.4 and 2.5), which also included the recording of 
interviews and possible publication of quotes, and the assurance of confidentiality, 
anonymity and voluntary participation.  
 Guided by the subject of interest and research method, a stepped approach to 
data collection was adopted, proceeding in three stages (Figure 1). As such 
recruitment was undertaken in three phases.  
 
Sensitivity to context 
 Commonly in GT, literature review is undertaken after analysis is formed.  
Despite awareness of the debate regarding this (as outlined by Charmaz, 2003), 
relevant literature on team formulation was reviewed before commencing data 
collection. This was required by the research proposal form needed for a clinical 
psychology doctorate course. This review was seen as sensitizing the researcher to 
gaps in knowledge (Hutchison, 1993). However, aware of the importance of 
approaching the research area without preconceptions or pre-formed ideas, reviewed 
literature did not form the basis of emerging theory, but served as a guide for initial 
sampling, procedure and developing initial interview questions. Open discourse was 
encouraged during the initial interviews to gain insight into participants experiences 
with formulation and care.  A stepped approach of data collection ensured that 
interview questions remained flexible while being adapted to evolving theoretical 
understanding. For example, based on emerging themes following the first phase of 
interviewing the researcher reflected on the socially constructed nature of MDT 
formulation and the dominance of particular staff ‘voices’ due to hierarchical order 
which led to theoretical sampling of non-senior staff members in phase two to allow 
‘quieter’ staff voices to be heard. Interview schedules for each phase were informed 
by analysis of data collected in the phase preceding it (Appendix 2.6). 
 Furthermore, to stay sensitive to context, the project was supported and 
actively guided by the existing Principal Investigators Steering Group, made up of 
senior staff members representing all teams in the service, comprising psychiatrists, 
psychologists and nurse team leaders. This group is responsible for oversight and 
management of the wider CSO funded study (see above) and has been granted 
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managerial approval. They provided advice and feedback (e.g. development of semi-
structured interview schedules). Liaising with them was hoped to ensure the project 
fitted with the social context in which it was situated, for example by receiving 
advise on setting of and approach to recruiting and interviewing the different 
participant groups.  
 In addition, the researcher attended MDT formulation sessions in each team 
and two training days on using compassionate reformulation to be sensitized to 
processes, issues and understandings of formulations by staff in these settings.   
 
Commitment and rigour 
 A total of fourteen interviews with fourteen participants, lasting between 15 
and 65 minutes each, were undertaken and then transcribed by the researcher. 
Transcription took around 3-12 hours each. The length of interviews was flexible, 
guided by participants’ engagement and preference. The majority lasted between 45-
60 minutes. One service-user preferred providing information in written format 
instead of being interviewed, resulting in a total of fifteen transcripts that were 
analysed. 
 After each interview, the researcher documented personal reflections to 
encourage reflexivity, for example with regards to potential bias introduced by 
personal role in the social construction of interview discourse. Furthermore, memos 
were written from the outset where initial coding ideas were noted. Combined, this 
documentation facilitated the simultaneous involvement of the researcher in data 
collection and analysis, shaping subsequent data collection decisions and 
construction of emerging themes. The fifteen transcripts were manually coded line 
by line and then subjected to focused coding. This in-depth engagement with the data 
ensured that emerging tentative categories remained grounded in the data. Continued 
memo writing and recording of thoughts about emerging categories helped to 
advance codes and sensitised the researcher to areas in need of clarification or 
further exploration.  
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Table 2: Example of line-by-line coding (codes eventually subsumed by the category 
of ‘Value and Function’) 
 
Transcript text Line Codes 
So, it’s a way of actually saying “This is a real 
person!”As opposed to a patient, maybe. And uhm 
“Do we, can we know what uhm - - ultimately uh is 
motivating this person, is, can we get to know this 
person!” You know, so I think it’s that kind of - - uhm - 
- - it’s just that kind of increased, it’s that space to 
think about someone - - in a way that uhm - - frees up 
or validates - - an individual’s attempts to engage with 
them. “I know, I feel like know this person! I feel I can 
think about them - - I feel like what I’m doing with this 
person makes sense - - there’s a rationale for doing it! 
There’s some theory, or something that’s backing us 
up, in terms of our, of our intervention.”   
Seeing the person, not a patient 
 
Understanding motivations 
Getting to know the person 
 
Having space to think  
Opening up and validating 
Attempting to engage 
Knowing the person  
Having space. 
Validating practice; Having a rationale 
Backing up intervention 
 
Transcript 4, p 13, 343-356 
 
 The method of constant comparison was used throughout the analysis 
process, examining data for similarities and differences within and between 
interviews, for example between statements, incidents, and codes. The process of 
comparative analysis and writing of more advanced memos facilitated clarification 
of emerging theoretical ideas to allow for systematic categorization of the data. For 
example, this process helped to identify shared properties between ‘wanting 
answers’ and ‘understanding of process’ leading to these themes becoming 
integrated meaningfully in the sub-category of ‘negotiating roles’. The emerging 
categories and ideas were discussed in bi-weekly meetings with the researcher’s 
supervisor. All transcripts and key memos were reviewed and a subset of the 
interviews coded by the supervisor. This helped to validate emerging categories, 
reducing researcher bias, while keeping them focused and grounded in the data.  
 During the first phase of analysis (psychologist interviews), the interview 
formed the basis for emerging theoretical ideas, feeding into theoretical sampling 
used in phase 2 to help elaborate and further explore emerging conceptualisations. 
Theoretical sampling continued following phase 2 until theoretical sufficiency was 
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achieved. In line with Dey (1999), theoretical sufficiency was indicated when no 
new relationships or codes emerged from the data analysis and categories were 
deemed to be coping adequately with new data, without requiring continual revision. 
In an attempt to avoid forcing data into categories to reach sufficiency, the researcher 
remained open and flexible, revisiting earlier data and, if required recoded them 
whenever questions about emerging categories emerged. Triangulation of the 
different views of professionals and service-users was used to develop a more 
comprehensive understanding of the subject of study and enabled determination of 
fit and relevance of emerging categories through methods of constant comparison. 
Data triangulation between different groups was judged to be an acceptable way to 
reduce bias and ensure a level of internal validity (Guion, 2002; Golafshani, 2003).  
 
Figure 1: Phased approach to data collection and analysis 
 
 
 
 
 
 
 
 
 
 
Transparency and coherence 
 The researcher remained aware of the context in which the interviews 
occurred throughout. The study was carried out as part of her doctorate in clinical 
psychology. Her relative inexperience clinically allowed for the participants to be in 
the position of experts. The researcher had some experience of working with people 
with psychosis and a sound understanding of individual case formulation, as well as 
an emerging knowledge of team formulation due to her studies and placement 
experiences over the past three years. During the research period of approximately 
18 months, the researcher completed an advance practice placement in one of the 
teams in which the research was set. This meant that some of the staff participants 
Phase 1: 
Psychologists 
Phase 2: 
Non-
psychologist 
staff 
Phase 3: 
Service-users 
Analysis Analysis 
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were known to the researcher, either from joint team working or clinical supervision. 
Also, the researcher was not a detached observer but active participant of the 
research by taking part in the team’s discussions and practices. The interest in the 
subject of study developed on the back of increasing experience of working in 
different settings and MDTs, and being exposed to different team practices and 
approaches to working with service-users with complex presentations. It spurred on a 
desire to better understand the process of team formulation and the potential value to 
staff and service-users. The excerpts were chosen on the basis of having facilitated 
pivotal insight, for example on the links between’ role clarity’ and ‘felt pressure’, or 
for explaining variation in the theory.  
 Reflections and experiences throughout the research process were discussed 
regularly in supervision with the researcher’s supervisor. The researcher was a 
novice to GT, and her relative inexperience with the method required her to be 
supervised more closely.  
 
 
FINDINGS 
 
 For clarity, all dialogue is given in verbatim and italic. The researcher’s 
speech is in bold type and her responses are in parenthesis (e.g. uhum). Pauses in 
speech are indicated by dashes - , whereby one dash equals a one second pause. 
Interruptions in speech are indicated by slashes / assigned to the person being 
interrupted. Unfinished sentences are indicated by dots. 
 
 Derived from these data an emerging model of team formulation is 
constructed, which outlines the value of and important functions underlying 
formulation as well as key processes underpinning its practice and implementation. 
The over-riding theme emerging in participants explorations of their experiences was 
that of ‘Shared understanding’, underpinned by sub- categories of ‘Value and 
function’ as well as ‘Processes’. Shared understanding was seen to support better 
engagement and ultimately better service-user care to support recovery. 
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Figure 2: Emerging model of team formulation 
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Core category: Shared understanding 
 Constructing and deriving a shared understanding of a service-user in his/her 
system was seen as a fundamental part and outcome of team formulation, facilitating 
a broader view and opening up alternatives for responding. Particularly to support 
the development of working relationships and promote engagement with service-
users to whom this is difficult. As such, shared understanding was seen as central to 
interactions between service and service-user and staff and service-user. At the same 
time, shared or mutual understanding with regards to the concept of formulation, its 
purpose and process, emerged as an important property with regards to the 
experience of team formulation, and the negotiations it demanded of staff.  
 
Value and Functions 
 As indicated, ultimately, the function and value of team formulation was 
understood as supporting engagement; the establishment and maintenance of 
working relationships with service-users to whom this is difficult to help the team to 
better support their recovery. Essentially, team formulation was valued for providing 
a place to which concerns about a particular service-user can be brought to and better 
understood in order to generate alternatives to the service’s approach to that person. 
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And I think it get, it [compassionate reformulation] does give us an avenue to 
explore and think about - - the patients that traditionally haven’t done very well in 
the service, and probably won’t do very well in other services, that are often very 
difficult to engage and how we can engage them differently. (Participant 2, p 30, 
783-787) 
 
 In order to achieve the overall aim of improving care for people at risk of 
arrested recovery, a number of processes were seen as essential. Fundamental was 
the construction of a better and shared ‘understanding’ of the service-user and the 
factors that may obstruct recovery. This was facilitated by a process of ‘broadening 
perspectives’, which was seen as important to promote change in the way the team 
respond to a service-user and plan interventions. As such, team formulation was 
constructed as serving an important function with regards to increasing 
understanding that can facilitate alternative responding and planning of MDT care. 
 
Understanding 
 Staff participants valued team formulation for providing an opportunity to 
share and integrate information derived from multidisciplinary practice and 
viewpoints. It was described to facilitate the construction of a fuller understanding of 
a service-user, an opportunity to ‘get to know’ a person better, and help the team to 
make sense of their responses by integrating various factors. For example 
consideration of how developmental history and attachment style can impact on 
people’s interpersonal and help-seeking style.  
 
And I suppose that through formulation - - - - I suppose you kinda notice - - like 
people fling bits up and, you know, when their putting it on the boards and things 
like that and you’re sharing all that information - - sometimes kinda gives you a 
better understanding - - of - - the person - - - and what it’s - - I suppose - - give you 
an understanding of them and some of how the - - behaviour why they do things. 
(Yeah) - - - I suppose that’s kinda makes a bit more sense. - - So I think - - it gives 
you a bit more understanding - - of the person. (Participant 8, p 2 33-56) 
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 Shared understanding was a theme emerging in service-user accounts, 
mirroring themes present in staff constructions. Service-users described consistency 
in staff responses that made them feel ‘known’ and met their needs. A mental model 
shared by the team and the service-user emerged as important for building 
relationships that feel acceptable to the service-user. 
 
[Keyworker]’s pretty well in the know about the my passage in life - - ehm Celtic 
history and things like that. And the lady that came the other time actually asked me 
about these things! And I think at times that is what I need - just for somebody to 
listen to my ramblings, you know what I mean? (Participant 10, p 19, 585-599) 
 
Broadening perspectives 
 Essential to the construction of a shared understanding was the process of 
opening up perspectives. The multidisciplinary context played an important role 
here, with people from different professional backgrounds chipping in to facilitate a 
broader, more integrative and holistic view of a person as opposed to one based on a 
singular perspective. It was constructed as a way to facilitate flexibility of thought. 
 
I think that that’s a strength of formulation as well - - that way of - - - - I think when 
you’re working with someone quite often you, you can get quite entrenched in it - - 
and then it takes someone who’s not involved to actually say: “Wait a minute, have 
you thought of that?” (Participant 6, p 5, 140-144) 
 
 Team formulation offered a way of constructing a more comprehensive 
narrative, incorporating multiple schools of thought (e.g. psychological, psychiatric, 
social) leading to a more truly biopsychosocial understanding as opposed to a 
singular perspective that can limit and constrain resources for responding.  It allowed 
for the recognition of the complexity of human suffering and resultant needs, and as 
such opened up scope for more varied responding. In this way, team formulation 
may have an important role in shifting cultures, particularly in areas of mental health 
previously dominated by a medical view.  
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For me in particular I think uhm - - sharing - - the uhm - - the focus, or spreading 
the focus out a bit and bringing in more psychosocial issues - - uhm is an integral 
part of the formulation process! (Umhum). If that wasn’t happening - - then I think 
it’d become, very quickly, - - very biologically, medically-driven - - treatment - - 
team. (Participant 3, p 31, 818-823) 
 
 However, the scope of team formulation with regards to broadening 
perspectives has the potential to go beyond understanding of the individual service-
user. Team formulation provided a place in which staff can make sense of their 
experience and their own responses.  It was recognized that working with a complex 
client group, particularly one where engagement is difficult or where the service-
users responses are at odds with treatment approach, can be challenging for staff.   
 
I suppose, what I think is helpful is that it - - ahh, for example, if I was stuck with 
somebody - - - - - so you’re presenting the information and I think what’s what’s 
good is that other people - - - - pick up on the information that you’re presenting - - - 
- and - - - it may be that I know…that I’m sitting with something that’s not feeling 
quite right, - - - - that’s a bit frustrating and I’m not quite sure why. - - And it’s that 
opportunity to get the whole story out, or as much as you can of the story out, and 
other people who can pick up those aspects and come in with suggestions as to why 
that may be. And that I think is is really helpful - - for me. (Participant 7, p 10, 293-
302) 
 
 Reflection on staff member’s own emotional response may be an important 
component of team formulation and core with regards to establishing relationships 
with service-users. For example, consideration of a service-users help-seeking style 
in the context of a team discussion and construction of a fuller understanding of that 
helped staff to take a different perspective. It facilitated reappraisal of the meaning of 
behaviours and situations, which served an important function in alleviating difficult 
feelings, leading to a shift in staff’s ability to be more empathic towards themselves 
and service-users. 
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I think increasing the team’s compassion and empathy – cause I really think the 
formulations do that when they’re working well. They definitely do - - make people 
feel more sympathetic for the patient and more able to understand why the person 
might annoy them, or frustrate them, or not answer their calls, or whatever. - - And 
to be able to reappraise that as ‘not personal’, to be so that so you can actually see 
staff using it to almost de-personalize - - the patient’s reactions (mm-hm), rather 
than it’s about them being a useless nurse, it’s not at all! It’s about this person 
having real difficulties with - - you know, emotional contact or interpersonal 
relationships or whatever. So you can see people understanding it and therefore - - 
just that generally taking the heat out of the whole situation and looking after the 
person. (Participant 2, p 17, 418-431) 
 
 As such, team formulation served an important systemic role. It facilitated a 
broader understanding of systems, the way in which different components in a 
system interact and where they are blocked. In this context, the system referred to 
relates to the service-user suffering from psychosis. It is the system this person is 
embedded in, made up of the service-user, the team, and the family/social 
environment, which in turn is embedded in a wider system (for example the political 
and economic system). As in any system, change in one subsystem or component 
will have an effect on the other components (Bertanlaffy, 1968). That is, enhanced 
understanding of the service-user and reappraisal of the meaning of their behaviour 
can alleviate emotional responses of staff in a way that allows them to relate 
differently to a service-user and respond in a more helpful way, which in turn may 
facilitate better engagement.  
 
I think you have to you have to include - - - the keyworker or, you know, the team - - 
uh in the formulation - - in kind of in a similar way that you might include a family in 
an individual’s formulation (mm-hm). So, in in a way it’s a, kind of a, I suppose it’s 
just an extension of the system around a - - particular patient. Uhm, so you’re trying 
to include as much of that because you’re working with all of it a lot of the time. 
(Participant 4, p 5, 129-134) 
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Flexibility, consistency and empathy 
 Responding was an important theme in participants’ reflections on team 
formulation. The broadening of perspectives and resultant shared understanding was 
constructed as providing the basis for discourse about current way responding, and 
alternatives to that.  
 
I think, you know, when the team has a shared sort of mental model - - of - - the 
service-user in their family context, in their developmental context etcetera. When 
when the service has a kind of flexible model of that it means that - - uhm - - the 
service can respond flexibly (uhum) but also consistently as well. So it means that, 
you know, if the keyworker is off -- and the service-user contacts the service there’s a 
continuity of care because of the shared narrative - - about the service-user. It 
means that, if there’s a crisis - - you know, there’s there’s the a kind of resource that 
the keyworker has; in terms of kind of flexibility of thinking, but also flexibility of 
support within the team to enable, you know, a kind of a a - - to enable the service to 
respond flexibly in crisis, rather than to respond in a kind of more kneejerk way. 
(Participant 1, p 15/16, 459-471) 
 
 Importantly then, team formulation may bring about responding 
characterized by flexibility, consistency and empathy. All of these aspects are 
essential components for engaging and building relationships that feel safe and 
supportive, and as such are fundamental for facilitating engagement. Consistency 
creates a sense of reliability which may be particularly important for service-users 
whose attachment histories have been barren of this. Equally, empathic and 
compassionate responding is essential for establishing supportive relationships, tying 
in with feeling accepted and safe. As such, team formulation can serve an important 
function in facilitating the establishment of relationships that can support recovery.  
 
 Consistency and trusting relationships were important themes emerging in 
service-user accounts. All of the service-users highlighted the importance of these 
aspects to be at the core and fundamental to their recovery. Having someone there 
that understands them and responds to their needs consistently and appropriately 
appeared to facilitate a sense of trust and safety.  
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It’s just patience, more or less for me. They had - - just for to talk to, somebody to 
talk to. [Keyworker] - -  she does my depot, as well (right) - - which I get every three 
weeks. And - - [keyworker] - - she just it’s just the relationship we built up. And it’s 
amazing! - - -  It’s amazing. I get her every week. I talk to her about everything I 
wanna I talk to her and I can tell her everything, really (uhum). - - Eh that was 
that’s been good - a good healthy relationship. (Participant 11, p 2, 32-45) 
 
 Equally, the process of constructing a shared narrative and broadening 
perspectives was seen as a process that facilitated flexibility with regards to 
responding; allowing a response attuned to the individual and his/her family’s needs, 
rather than prescriptive or limited (e.g. based on a diagnostic category). 
 
I was in when I was in the [hospital] - - eh I kept thinking about the twin towers - - 
and - - eh [keyworker] came in and spoke to me about it and it really put me at ease! 
- - It really put me at ease. And the support they’ve gave me since I came out of 
hospital. They’ve been times when I heard voices - - and times when I haven’t been 
hearing voices. - - But at times when I have been hearing voices [the service] has 
been there to talk me through it. And come and visit me and make sure I’m alright. 
(Uhum). And also they’ve helped me when I’ve been getting psychotic thoughts, - - 
to stop the psychotic thoughts as well and nip them in the bud before they get worse. 
(Participant 13, p 4, 111-124) 
 
Giving direction 
 For staff, team formulation was also valued for providing possible solutions 
or direction. It was seen as a way to support the team with difficult to engage 
service-users by giving them a platform to discuss struggles and concerns, make 
sense of this and offer or receive advice about possible alternatives to responding 
and intervention. For some, team formulation was constructed as essentially 
solution-focused, a ‘means to an end’, directing treatment planning, providing 
answers, and helping to solve problems. Others constructed the value of the process 
in a broader sense, which included constructing a story, getting to know a service-
user, widening perspectives, getting support with and validation of their work, and 
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facilitating more holistic and person-centred responding to support someone’s 
recovery. Differences with regards to people’s understanding of the purpose of 
formulation shaped their expectations of the process, as elaborated on below. 
 
I s’pose trying to - - work out at a kinda what’s the best kind of care plan to be going 
with and…Quite often we’ll have patients who you think: “Well - - BFT might be an 
appropriate intervention but also individual psychology might be an appropriate - - 
intervention. Or occupational therapy might be an appropriate intervention.” - - I 
s’pose the formulation process is - - well it prioritizes things a bit - - more clearly. 
Uhm uhm - - - - - - - and I think, you know, it - - they kinda highlight gaps where - - 
we know or we haven’t actually - - had this conversation with the person’s parents 
or we haven’t had this conversation with - - somebody else. It opens up different 
avenues to - - work and to - - uh I s’pose it can help us also with, you know, just 
engaging with some of the people who are a bit more difficult to engage. - - We can - 
- - - get a bit more insight as to to why they’re difficult to engage - - and work 
around that. (Participant 9, p 9, 250-267) 
 
 In this way, team formulation took an important place in treatment planning 
and the provision of a person-centred and shared approach to care. Importantly, 
service-users felt included in this process and experienced their care as flexible as 
opposed to fixed and predetermined. 
 
I feel that throughout my time with [the service] there was always a pretty clear plan 
in place to help me.  I feel that I was always given the opportunity to discuss what 
this plan should involve and give feedback on what I felt was working and what I felt 
was not so useful. (Participant 15, p 3, 60-64) 
 
 Ultimately, team formulation was understood as a means to construct a 
shared narrative that facilitated a broader systemic view and identification of barriers 
within the system. This was providing a context in which flexibility and consistency 
in understanding and response could develop to support the team and service-user in 
their attempts towards recovery. Importantly, it provided a context for developing 
important prerequisites for better relationships between service-service-user, staff-
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service-user and potentially staff-service. Simultaneously, it gave scope to develop 
flexibility and the establishment of a care plan responsive and better attuned to the 
needs of a service-user. As such, team formulation was constructed as an important 
tool to support person-centred care and fundamentally support recovery.  
 
Processes  
 As described above, team formulation was a valued practice overall, seen to 
be serving an important function in supporting the team, individual staff members 
and service-users in their journey of recovery. Importantly, the data provided insight 
into and highlighted processes that underpin the construction of team formulation, 
needing to be negotiated or managed by staff in order to achieve the above goal. This 
related to expectations and uncertainty.  
 
Negotiating roles 
 Team formulation was a context that required negotiation and clarification of 
roles and tasks. It was a context where different professional roles were played out, 
for example by utilizing and appreciating expertise and experience from the different 
disciplines.  However, the data indicated a level of uncertainty with regards to one’s 
role and place in the production of formulation, which led to blurred expectations. 
Team formulation appears to necessitate clarity about what is expected of each staff 
member and the process itself.  
 
I don’t know, I don’t know if people expect or even, like the psychologists say “Right 
ok this is, you know, like a clear plan, this is what we should do”. But I don’t know if 
that’s necessarily…it should be still multi-disciplinary and - - - I don’t know if they 
expect - - psychology to come to some conclusion at the end about - - what they’re 
doing or where it goes or (uhm) - - or how their treatment goes, I don’t know. 
(Participant 8, p 12/13, 361-367) 
 
 Clarity about professional roles was linked to clarity of expectations held 
internally by staff as well as perceived expectations of their performance placed on 
them by others. The level of clarity around this shaped the way team formulation 
was experienced. Lack of clarity with regards to one’s role in the process and 
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expectations deriving from this had the potential to give rise to difficult emotions 
such as doubts over professional competency, or feeling under pressure or exposed.  
 
As keyworker however, I think sometimes there is - - a felt pressure - - to come with 
all the information - - at your finger-tips (uhum) - - when [ ] we are doing the 
formulation. - - - And although [ ] we talk about these things as a team - - - - we talk 
about that that’s not possible and that, you know, that we’re not gonna have all that 
ahm, I do sometimes feel that pressure ahm when when you when you don’t have all 
the information at your fingertips. Even though logically you know it’s it’s not 
possible.  You know some of the clients that we work with that perhaps are seeking 
asylum or have no family or whatever whatever whatever we can’t we can’t possibly 
have all that information there. Ahm so logically, you know, I know that but but 
sometimes there is still a felt pressure when - - you know you’re you you don’t know 
- - things that folk are asking you. (Participant 7, p 3/4, 76-90) 
 
 Team formulation also gave rise to negotiations of expectations related to the 
role of the process itself. Comparing two reflections on the use of compassionate 
reformulation (below) gave valuable insight into the way in which differences in 
understanding influence expectations and the experience of the process.  Team 
formulation therefore required staff to manage uncertainty and negotiate meaning.  
This supported the need for clarity and shared understanding of the process of team 
formulation.  
 
And often it’s really difficult - - for staff working with people when they see that - - 
they’re stuck, and they’re not getting better. [ ] So - - they uhm they can come and 
talk about all of that - - (mm-hm) in a safe place, with no expectation that, at the end 
of it - - we have to have an answer! (Participant 5, p 10, 320-326) 
 
This excerpt was contrasted with the following: 
 
But with the compassion - - reformulation - - I think there’s maybe a sense within the 
team that - - we don’t have that [direction]. It’s somebody we don’t know, somebody 
we don’t understand - - and we talk about what we don’t know, what we don’t 
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understand. - - And we probably don’t come away with that same sense of - - - 
knowing where we going next. Sometimes it helps us understand that there isn’t uhm 
much else that we can…you know the path that we’re on is the path that we’re gonna 
have to stay on. But I think - - there’s an expectation that - - it would be - - providing 
more answers then it perhaps does. (Participant 9, p 2/3, 48-57) 
 
 What emerged from the accounts overall was the need for staff to negotiate 
roles, meaning and expectations and that this can be challenging. Clarity and shared 
understanding therefore appear paramount.  As such, fundamental to team 
formulation appears to be the availability of a space or system that allows staff to 
articulate  concerns and uncertainties. A process that enables clarification of roles 
and tasks in order to facilitate mutual or shared understanding about what everyone 
contributes and what is expected from the process.  
 
Managing uncertainty  
 Uncertainty and the need to tolerate and manage this appeared to be an 
inevitable component of team formulation. This related to processes involved as well 
as the outcome of it, namely the process of exploration and the construction of a 
hypothesis about someone. Both have uncertainty as inherent properties; while 
simultaneously serving to reduce it. In order to understand someone’s difficulties of 
engagement or with building relationships requires exploration of the systemic 
factors contributing to it, including e.g. staff feelings and responses. It requires 
openness, reflection and willingness to explore and make inferences about the 
unknown. This then can facilitate understanding that may direct the team towards a 
solution However, as with any formulation, the understanding constructed remains a 
hypothesis, not a truth. While this is a practice familiar to, say, psychologists, it may 
be less so for other disciplines, therefore being potentially harder to tolerate and 
accept. This then can impact on their engagement with the process.  
 
So that’s that’s always ahm a bit of a concern of mine that - - we’ll be speculating 
and and throwing ideas on the table - which I think is very much what ahm - - - 
formulation can be about I think…that’s you know what…that it’s…formulation 
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allows us to do that! - - (Uhum). - - But I do worry sometimes that speculation does 
become fact! (Participant 7, p 5, 119-124) 
 
 Unfamiliarity may be underlying some of this. But participants’ accounts also 
indicated the role that heightened levels of stress can play. Working with a complex 
client group, with people who are very unwell and whose recovery is slow or 
stagnant can add urgency to staff’s sense of having to achieve a change, and lead to a 
desire of getting clear answers and solutions. Uncertainty may be particularly 
difficult to tolerate when stress and anxiety levels are high, when staff feel unable to 
support a person in their recovery. However, what emerges from these data is that 
exploration and construction of hypotheses are necessary processes to be able to 
generate ideas and solutions. As such, the management and tolerance of uncertainty 
appear to be core parts of team formulation. Again, what seems vital is for team 
formulation to provide a space that feels safe enough for staff to express their 
concerns, to articulate their unease with these practices and develop ways to manage 
uncertainty around that.  
 
Creating space 
 As indicated by the construction of participants’ experiences of team 
formulation, ‘space’ was an essential ingredient - the availability of space in which 
people felt included and free to explore, safe and non-pressured.  A space that has 
the potential to provide a context for processes to occur, unfold and be negotiated as 
required in order to achieve mutuality of understanding of the person and the process 
of team formulation. 
 
[…] For me that reflective space has certain properties to it - - It’s a space that is 
well defined - - and - - it’s a space that kind of feels safe - - free from judgement […] 
It’s a space where people feel free to express their views and express their opinions 
[…] both positive and negative. And it’s a space that - - - encourages and values 
curiosity and exploration. And for that reason you have to have the kind of the 
feeling of safeness and non-judgement that go along with with that. I think that’s a 
really crucial aspect of team formulation and the team formulation process. 
(Participant 1, p. 10, 260-267) 
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 It was acknowledged that having space was important for essential 
ingredients of team formulation, namely reflection and exploration, but that it can be 
challenging to provide this space. The availability of space was at the mercy of 
factors internal and external to staff and the team, including practical aspects such as 
having enough time, procedures used for facilitating formulation, and organisational 
stressors, as well as ability of staff to engage.  
 
So, I think that’s a challenge of trying to do the best that you can within the, you 
know, a short, fairly short period of time - - and trying to make sure that everyone 
feels their voice is heard. (Participant 5, p 24, 634-637) 
 
 
DISCUSSION 
 
 This study set out to explore experiences of team formulation and care from 
multiple perspectives, including MDT staff and service-users, in the context of an EI 
service for people experiencing first episode psychosis. Team formulation is a firmly 
established practice in this service, supporting work with this complex population. 
Using a social constructionist approach of GT (Charmaz, 2003; 2006), this study 
constructed an emerging model of team formulation in collaboration with the 
participants. Arising from the data, two levels comprising this model were 
established: the ‘value and function’ of team formulation and ‘processes’ involved in 
it.  
 The narratives indicated that team formulation was a valued practice overall. 
Ultimately, its value and function was understood to lie in the construction of a 
shared understanding that helps the team to support service-users who have been 
identified as at risk of arrested recovery due to difficulties engaging with the service. 
Fundamental to the construction of a shared understanding was the process of 
broadening perspectives, of taking a systemic view. In this way, the findings are in 
line with benefits highlighted by previous studies into the use of team formulation 
(e.g. Dexter-Smith, 2010; Hood et al., 2013). As in other studies (e.g. Summers, 
2006; Wainwright & Bergin, 2010; Christofides et al., 2012), the data highlighted 
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the value of team formulation for promoting empathy, better relationships with 
service-users, and interventions more attuned to their needs. Importantly, this study 
advanced understanding by pointing towards processes underlying this, such as more 
flexible, yet consistent responding from the team. In this way, team formulation may 
have the potential to promote the establishment of better relationships with service-
users to whom this may be difficult. Importantly, increasing knowledge of the role of 
developmental factors was seen as valuable in helping the team to understand 
service-users responses. Equally, broadening understanding to include and address 
wider systemic factors, such as the role of service’s and staff’s responses, was core 
in helping staff to make sense of interpersonal challenges. An important addition to 
the existing literature about team formulation has been the emerging understanding 
of processes underpinning this practice, including negotiation of roles, managing 
uncertainty and creating space. It emerged that doing team formulation by itself was 
not enough, but that it required staff to engage with and negotiate processes in order 
to construct it. What emerged was that this can be experienced as challenging by 
staff, and therefore influence their ability and willingness to engage in formulation 
and essential components of such (e.g. exploration). It highlights the importance to 
develop systems or space in team formulation where these processes and related 
concerns can be articulated in order to facilitate a shared understanding that clarifies 
and results in mutuality of expectations. In this way, potential strains involved in 
doing formulation for staff may be reduced, thereby increasing or easing their 
engagement with the process. The availability of a space that feels safe and 
facilitates exploration has been emphasized by Johnstone (2014) as a core ingredient 
of team formulation. While the importance of such space was indicated by these data 
also, it highlighted challenges inherent in establishing and maintaining reflective 
space due to various factors, such as time pressures or team dynamics. Consideration 
of the context of working with service-users with complex difficulties and the impact 
that has on staff also seems important here. Staff participants acknowledged the 
challenges and stresses related to working with this group, and particularly with 
service-users who struggle to engage with them and with treatment. Difficulty 
engaging service-users may be challenging to staff for various reasons, including 
doubts regarding their competency and concern for the service-user (e.g. 
consideration of the link between duration of untreated psychosis and poorer 
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outcome). The felt pressure and anxiety resulting from this may have important 
implications for staff’s way of responding. Indeed, a recent study into the use of 
advance statements indicated that staff tended to resort back to more limited and 
coercive treatments in the face of crisis as opposed to taking a more flexible and 
person-centred approach (Thornicroft et al., 2013). Importantly, increased stress and 
pressure may significantly impact on staff’s ability to engage in reflective practice 
and the process of exploration due to a felt urgency to act. Some participants 
highlighted the way in which heightened stress led to a more action-driven approach 
to formulation, a desire to get answers and solutions as opposed to exploring.  While 
it is important to be mindful of this, it simultaneously strengthens the case for using 
team formulation to help reduce some of the strain for staff by finding ways to 
engage this group.  
 
Clinical implications and future directions 
 The model emerging from this exploration has provided important insight 
into team formulation and processes underpinning it. This may be of value to help 
advance this practice and its application in order to improve outcomes for individuals 
at risk of arrested recovery. For example, by developing team processes and space in 
which staff experiences with and concerns about formulation can be addressed and 
mutual understanding reached. It also may provide a point of departure towards 
developing a more comprehensive model and theory of team formulation to facilitate 
further, more rigorous research into its use (e.g. outcome studies) and promote 
dissemination of this approach to other services. 
 
Limitations 
 The constructed model of team formulation presented here was based on 
fifteen participants’ perspectives and the researcher’s analysis of this. The results are 
one possible construction of these data, and the current presentation bound to the 
context and conditions of this study (Hutchinson, 1993). Any given text permits 
infinite interpretations; therefore lengthy excerpts were included here to allow 
readers to make their own interpretation. It could be argued that further respondent 
validation may have been beneficial. However, the researcher was aware that data 
collected in response validation is subject to the same process of interpretation 
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(Bloor, 1997). To strengthen validity, triangulation and review of the data by a 
second person were used (Guion, 2002). While valuable insight into team 
formulation was gained, causal relationships cannot be assumed. Any suggested 
relationships require further quantitative evaluation in order to make inferences of 
causality. Having used a social constructionist approach to GT (Charmaz, 2003; 
2006) the researcher has emphasized reflexivity throughout to stay aware of her own 
role in and contribution to the process of construction. Still, her professional role, 
proximity to the service and participants, and personal beliefs need to be taken into 
account.  
 The analysis of service-user accounts alongside those of professionals and 
triangulation between these two groups proofed to be challenging. Service-users in 
this service are not actively part of team formulation and as such were interviewed 
about their experiences of care, while staff participants were interviewed about their 
experiences of formulation. The difference in interview topics between the staff and 
service-user participants may account for the difficulties encountered when 
constructing the data and clearly limit the links that can be made across data. On 
reflection, it may have been more meaningful to analyse and construct these data 
separately.  
 It may be argued that other qualitative methods could have been employed 
for this study. While Interpretative Phenomenological Analysis (IPA) (Smith, 1996) 
is an approach specifically developed to explore psychological worlds, committed to 
people’s lived experience, it focuses on small, homogenous sampling and does not 
specifically aim to generate a theory or explanatory framework (Smith, Flower & 
Larkin, 2009). Increasing a more theoretical understanding of team formulation by 
exploring the experiences from multiple perspectives was however the aim of this 
study. GT allows for theory generation by taking a phased approach to data 
collection and using memos to create theoretical links across heterogeneous 
accounts. It was therefore felt suitable for managing the wealth of data derived in 
this study.  A possible alternative may have been Framework Analysis (FA) (Richie 
& Spencer, 1994). Like GT, FA is a method that generates theoretical understanding 
firmly grounded in participants’ accounts, allowing for flexibility during data 
collection and analysis to adjust to emerging theoretical concepts, and allows 
working with comprehensive sets of data making links across accounts (Srivastava & 
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Thomson, 2009). Unlike GT, FA has scope to answer questions more specifically 
and allows for more generalizability. As such, it would have allowed for the 
incorporation of existing understandings of team formulation and a more directive 
approach, which may have been valuable. However, given the lack of consensus 
currently present with regards to applications of team formulation, FA would have 
been difficult to be applied in this context.   
  
Conclusion 
 In summary, this study constructed an emerging model of team formulation 
in the context of an EI first episode psychosis service. The importance of shared 
understanding of a service-user and his/her needs, as well as the process of 
formulation has been highlighted.  In order to achieve this, reflective space allowing 
for articulation and negotiation of roles and uncertainty are central to arrive at a 
shared understanding and mutuality of meaning. Further, fundamental processes 
underlying the establishment of working relationships attuned to individual needs 
have been outlined (e.g. broadening perspective and increasing flexibility, 
consistency and empathy).  
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ABSTRACT 
 
This reflective account describes a challenge I faced with regards to striking the 
appropriate balance between communicating and sharing information in a team, 
while staying in my professional role and keeping up good ethical practice. I have 
chosen to reflect on an experience I had while on placement in an adult specialist 
service that highlighted this challenge. It describes a situation of information-sharing 
about a specific service-user between me and two other professionals in a shared 
office space. The way this person was being discussed in an open space left me 
feeling uncomfortable and uneasy. Using a number of models of reflection helped 
guide my reflection in a way that facilitated learning about a number of important 
issues, including ethical practice, relevance of identifying and exploring difficult 
emotions, making sense of dynamics, taking a broader view, and the way that 
organisational and systemic factors can influence behaviour. This exercise allowed 
me to lift my understanding of a specific situation to a more advanced level, 
facilitating learning about how to enhance my own clinical practice and inform better 
care in the wider system. 
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ABSTRACT 
 
This reflective account describes the challenge I have faced of finding ways to 
promote psychological understanding in a service stretched to its capacities where 
the medical view is still predominant. The experience I have chosen is the discussion 
of a new referral at the weekly MDT meeting that highlighted this challenge very 
clearly to me. The experience allowed me not only to clarify my own professional 
identity, it has also given me scope to reflect on current challenges faced by services, 
demand and capacity issues, and the way in which this may impact on person-
centred approaches to care. It has given me the opportunity to think about different 
service delivery models and approaches to meet current challenges, MDT work and 
the role of psychologists within that. Making use of reflective models helped guide 
my reflection in a way that facilitated learning to allow me to generalize my acquired 
understanding to my clinical practice and the wider context, and helped me identify 
important areas for continued professional development to help prepare me to meet 
the challenges faced by services with regards to increasing access to psychological 
therapies in the future.      
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APPENDIX 1 – Systematic Review 
 
Appendix 1.1 - Author Guidelines for Submission to Schizophrenia Research 
 
SCHIZOPHRENIA RESEARCH - Guide for Authors (For full details see: 
http://www.elsevier.com/journals/schizophrenia-research/0920-9964/guide-for-authors) 
Aims and scope:  
Schizophrenia Research provides rapid publication of new international research that 
contributes to the understanding of schizophrenia and related disorders. The journal brings 
together previously separated biological, clinical and psychological research on this 
disorder, and stimulates the synthesis of clinical and research data into cohesive 
hypothesis. 
Presentation of manuscript:  
Please write your text in good English (American or British usage is accepted, but not a 
mixture of these). Italics are not to be used for expressions of Latin origin, for example, in 
vivo, et al., per se. Use decimal points (not commas); use a space for thousands (10 000 and 
above). 
Provide the following data on the title page (in the order given). 
Title. Concise and informative. The title should indicate the main point of the manuscript. 
Note that titles are often used in information-retrieval systems. Avoid abbreviations and 
formulae where possible. 
Abstract. A concise and factual abstract is required (maximum length 250 words for full-
length papers or 100 words for short communications). The abstract should state briefly 
the purpose of the research, the principal results and major conclusions. An abstract is 
often presented separate from the article, so it must be able to stand alone. References 
should therefore be avoided, but if essential, they must be cited in full, without reference 
to the reference list. Non-standard or uncommon abbreviations should be avoided, but if 
essential they must be defined at their first mention in the abstract itself. 
Keywords. Immediately after the abstract, provide a maximum of six keywords, using 
American spelling and avoiding general and plural terms and multiple concepts (avoid, for 
example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in 
the field may be eligible. These keywords will be used for indexing purposes. 
Abbreviations. Define abbreviations that are not standard in this field at their first 
occurrence in the article: in the abstract but also in the main text after it. Ensure 
consistency of abbreviations throughout the article. 
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Arrangement of the article 
Subdivision of the article. Divide your article into clearly defined and numbered sections. 
Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ?), 1.2, etc. (the abstract is not 
included in section numbering). Use this numbering also for internal cross-referencing: do 
not just refer to 'the text'. Any subsection may be given a brief heading. Each heading 
should appear on its own separate line. 
Introduction. State the objectives of the work and provide an adequate background, 
avoiding a detailed literature survey or a summary of the results. 
Experimental/Materials and methods. Provide sufficient detail to allow the work to be 
reproduced. Methods already published should be indicated by a reference: only relevant 
modifications should be described. Statistical tests used for evaluation of data should be 
briefly explained. In case of experimental studies, animals used should be described, 
including information on breed, breeder, sex, age, weight and the maintenance conditions. 
Special chemicals and their sources should be grouped under a separate sub-heading. For 
drugs generic names should be used; trade names may be given in brackets where the drug 
is first mentioned. In case of a new drug, a chemical description (formula) should be given. 
The form of a drug used should also be indicated. 
Results. In this section the findings should be described clearly, concisely, and in logical 
order without extended discussions of their significance. Only in case of short 
communications, the results and discussion sections may be combined. Results should 
usually be presented in graphic or tabular form, rather than discursively. There should be 
no duplication in text, tables and figures. Experimental conclusions should normally be 
based on adequate numbers of observations with statistical analysis of variance and the 
significance of differences. The number of individual values represented by a mean should 
be indicated. 
Discussion. This section should present conclusions to be drawn from the results 
accompanied by an assessment of their significance in relation to previous work. 
Speculative discussion is not discouraged, but the speculation should be based on the data 
presented and identified as such. In general, the discussion should be as concise as 
possible. 
References 
Citation in text 
Please ensure that every reference cited in the text is also present in the reference list (and 
vice versa). Any references cited in the abstract must be given in full. Unpublished results 
and personal communications are not recommended in the reference list, but may be 
mentioned in the text. If these references are included in the reference list they should 
follow the standard reference style of the journal and should include a substitution of the 
publication date with either 'Unpublished results' or 'Personal communication'. Citation of 
a reference as 'in press' implies that the item has been accepted for publication. 
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Appendix 1.2: Search strategy: Ovid MEDLINE (May 14
th
, 2014) 
 
 
01. (mindfulness or meditat*).mp. 
02. mindfulness-based.mp. 
03. compassion.mp. 
04. (acceptance and commitment therapy).mp. 
05. compassion-focused.mp. 
06. loving-kindness.mp. 
07. person-based cognitive therapy.mp. 
08. acceptance-based.mp. 
09. compassionate mind training.mp. 
10. dialectical behaviour therapy.mp. 
11. third-wave therapies.mp. 
12. third-wave therapy.mp. 
13. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 
14. (psychosis or psychotic).mp. 
15. psychotic disorder*.mp. 
16. schizophreni*.mp. 
17. schizoaffective disorder*.mp. 
18. schizophrenia-spectrum disorder*.mp. 
19. bipolar disorder*.mp. 
20. manic depression.mp. 
21. 14 or 15 or 16 or 17 or 18 or 19 or 20 
22. 13 and 21 
 
[mp=title, abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier] 
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Appendix 1.3: Data Extraction Form:  Characteristics of included studies 
 
Study:  
 
Participant 
characteristics  
Sampling  
Recruitment site  
Number of participants  
Age  
Gender  
Ethnicity   
Diagnosis  
Presenting problem (inclusion criteria)  
Inclusion/exclusion criteria  
Education level  
Employment status  
Medication  
Treatment history  
Attrition rate  
Setting  
Country  
Trial characteristics Year of publication  
Type of study  
Design  
Allocation  
Blinding  
Duration  
Therapist qualifications  
Type of outcome measures  
Follow-up time in weeks  
Characteristics of Number of participants   
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the Intervention Type of treatment  
Treatment protocol  
Length of treatment   
Attendance (N sessions)  
Length of assigned home practice   
Quality of home practice  
Treatment setting  
  
Characteristics of 
the comparison 
group 
 
Number of participants  
Type of control   
Type pf treatment  
Length of treatment  
  
Outcome 
 
Aim(s) of the study   
Key outcome(s)  
Other outcome(s)   
  
Results Attrition/participant-flow    
Primary analysis  
Secondary analysis  
Other outcomes/results  
Summary/Conclusions  
Notes (e.g. any 
omissions/missing 
data?) 
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Appendix 1.4: Data extraction sheet – Risk of bias 
 
Study name: 
 
 
Bias 
 
Author’s judgement (Level of risk (e.g. low, unclear etc) 
 
Support for judgement - Brief explanation of what 
judgement was based on (e.g. ‘no information provided’; ‘all 
stated outcomes were reported’) 
 
Random sequence generation (selection bias) 
 
 
 
 
 
 
 
 
Allocation concealment (selection bias) 
 
 
 
 
 
 
 
 
Blinding of participants and personnel 
(performance bias) 
 
 
 
 
 
 
 
 
Blinding of outcome assessment (detection bias) 
 
 
 
 
 
Incomplete outcome data (attrition bias) 
 
 
 
 
 
 
 
Selective reporting (reporting bias) 
 
 
 
 
 
 
 
 
Other bias 
 E.g. study design flaws? 
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 E.g. data collection was stopped early? 
 Etc. 
 
 
 
Overall Risk: 
 
 
 
 
 
 
Registered protocol? 
 Y/N Protocol same as 
reported? (Y/N) 
Risk of bias (Y/N) What differed? 
 
Current Controlled Trials Ltd  
 
 
   
 
Clinicaltrials.gov 
   
 
 
Australian and New Zealand Clinical Trials 
Registry (www.anzctr.org.au) 
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Appendix 1.5: Table of risk of bias judgements 
 
  
Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
 
Bach & Hayes 
(2002) 
 
       Bach et al 
(2012) 
Unclear Unclear Low High Low High High High 
Randomized, but 
not reported how 
 
‘Those who agreed 
to participate were 
randomly assigned 
(40 per condition) 
to receive 
treatment as usual 
(TAU) or the ACT 
intervention plus 
TAU’. 
 
Not described 
 
Rated as low due to 
lack of relevance of 
this criteria in this 
context given the 
nature of trials 
assessing the 
effectiveness of 
psychological 
therapeutic 
interventions.  
 
‘Baseline measures 
were collected by 
one of the 
investigators 
(Patricia Bach) 
immediately after 
the participant 
signed the consent 
form agreeing to 
participate in the 
study. Follow-up 
measures were 
collected by the 
participant’s case 
manager or by one 
of the investigators 
(Patricia Bach).’ 
 
 
Days to index 
hospitalisation 
were available for 
30 TAU participants 
(86%) and 33 ACT 
participants (94%).  
 
‘Four participants 
in each condition 
moved out of the 
area, and 1 in each 
condition died. 
Rehospitalisation 
data were available 
for 35/40 for each 
condition. 
Conceivably these 8 
participants could 
have been 
hospitalised 
elsewhere.’ 
 
Secondary 
outcomes: 
(symptom 
frequency, distress 
and believability) – 
Figure 4 presents 
believability 
ratings. No such 
figures presented 
for frequency and 
distress. 
 
Post hoc analyses 
of subgroups of 
ACT participants 
based on their 
reporting of 
symptom 
frequency are 
selective, comprise 
small n and lack 
statistical power for 
comparisons. 
 
Frequency of 
reporting 
symptoms is 
reinterpreted as a 
measure of 
acceptance of 
symptoms for 
subsequent 
analyses of distress, 
believability and 
speculation 
regarding 
mechanisms of 
rehospitalisation. 
 
No measure of 
other variables  
 
Previous 
psychological 
therapy history 
unclear 
 
Some received 
Due to detection 
bias and selective 
reporting. 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
In the follow-up 
paper post-
discharge 
hospitalization data 
for 1 year were 
available for 51 of 
the 64 participants 
(80%) with previous 
hospitalization 
information.  This is 
51 of original 
sample of 80 (64%). 
Imputation of 
missing data 
reduced 1-year 
hazard rate from 
254% to 97%. 
 
psychotherapy in 
hospital – no 
details provided   
 
 
Braehler et al. 
(2012) 
 
Rated by JH only 
Low Unclear Low Unclear High Low High High 
‘Recruitment, 
randomization, and 
running of groups 
in the three 
localities were 
staggered. When a 
block of at least 12 
participants had 
been recruited in 
one locality, 
Not described. Rated as low due to 
lack of relevance of 
this criteria in this 
context given the 
nature of trials 
assessing the 
effectiveness of 
psychological 
therapeutic 
interventions.  
‘A research 
assistant (SW) 
conducted 
assessments prior 
to randomization 
(self-report 
measures, 
Recovery Narrative 
Interview) and 
following 
In total, data for 
n=15 (CFT group) 
and n=17 (TAU) 
were included in 
final analysis (CFT 
attrition=31%) 
  
‘Attrition from CFT 
was 18% (4 of 22). 
The four CFT 
No selective 
reporting 
identified. 
 
Small sample size  
 
Not controlling for 
other variables, e.g. 
treatment history. 
Small sample size 
and incomplete 
data.  
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
Independent 
randomization was 
conducted by AG 
using a web-based 
computer-
generated 
permuted 
procedure 
(http://www.rando
mization.com). The 
first two groups 
were randomized 
at a ratio of 1:1 to 
CFT + TAU or TAU 
alone; the third 
block was 
randomized at a 
ratio of 2:1 in 
favour of the group 
to ensure a CFT 
group size of at 
least seven 
members.’   
 
completion of the 
group or respective 
wait (self-report 
measures, 
Recovery Narrative 
Interview, Clinical 
Global Impression 
Scale). The 
research assistant 
was masked to the 
allocation of 
participants. 
Further efforts to 
maintain the mask 
included locating 
the assessor in a 
building separate 
from clinical staff 
and advising 
participants not do 
disclose allocation 
in the follow-up 
interview. No 
formal evaluation 
of the masking was 
undertaken/effecti
veness of blinding 
was not formally 
assessed.’ (p 7)  
 
participants, who 
were unwilling or 
unable to complete 
post-assessments, 
had all dropped out 
of the therapy 
within the first four 
sessions. One TAU 
participant and 
three CFT 
participants 
refused the 
recording of the 
interview at post-
assessment due to 
feelings of 
paranoia. The 18 
completers 
attended for an 
average of 12 
sessions (SD = 3.6). 
One person in the 
CFT condition died 
of natural causes as 
determined by 
post-mortem 
examinations. 
There were no 
suspected 
unexpected serious 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
 adverse reactions 
over the course of 
the trial.’ (p 9) 
‘In the CFT 
condition, post-
assessment data 
were missing for 
five participants on 
self-report and for 
a further two on 
the interview. One 
TAU participant 
had failed to fully 
complete PBIQ and 
BDI and refused the 
interview at post-
assessment. All 
data available for 
this participant 
were included in 
the analyses.’ (p 7) 
 
 
Chadwick et al. 
(2009) 
 
Unclear Unclear Low Unclear Low Unclear High High 
‘The North Wales 
Organization for 
Randomized Trials 
in Health then 
allocated them at 
random between 
No details provided 
 
Rated as low due to 
lack of relevance of 
this criteria in this 
context given the 
nature of trials 
assessing the 
No details provided 
of who conducted 
assessments. 
21 participants 
randomised, 18 
analysed for 
‘primary analysis’. 
Drop outs from trial 
and intervention 
All primary analysis 
outcomes reported 
according to aims 
of study.  
 
Secondary analysis 
Small highly 
selective 
convenience 
sample of n = 22 
(from 35). Study 
aims to determine 
Small sample size 
and uncertainty 
about blinding 
assessor. 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
group- based 
mindfulness 
training and a 
waiting list for this 
therapy.’ (p 404). 
No further details 
provided. 
 
One participant 
allocated to waiting 
list due to ongoing 
medical problems 
and was removed 
from 
randomisation and 
feasibility analysis. 
Abstract is 
inconsistent with 
this (n = 22 rather 
than 21). 
effectiveness of 
psychological 
therapeutic 
interventions. 
not analysed. 
Primary outcome 
specified as clinical 
functioning (CORE). 
 
Reasons for drop-
outs stated: ‘Two 
people dropped 
out: one between 
assessment and the 
group starting (he 
began using heroin 
again) and one 
after one session 
(found it difficult to 
be in a group)’. (p 
408) 
 
of within group 
therapy 
improvements on n 
= 15 of those who 
complete 6 or more 
sessions (does that 
include WL 
participants? Not 
clearly stated) 
 
effect size 
estimates for larger 
RCT however not 
clear whether such 
a small sample size 
is adequate to 
determine sample 
size estimation. 
 
9 participants 
attended at least 6 
sessions – bias due 
to attending limited 
sessions? 
 
 
 
 
 
 
 
Chien & Lee 
(2013) 
 
Unclear Unclear Low Unclear Low Unclear High High 
Participants were 
randomly allocated, 
however procedure 
was not described. 
 
‘After their written 
consent had been 
obtained after a full 
No information 
provided. 
Rated as low due to 
lack of relevance of 
this criteria in this 
context, given the 
nature of trials 
assessing the 
effectiveness of 
psychological 
‘One trained 
research assistant 
who was blind to 
the group 
assignment 
administered the 
pre-test and two 
post-tests.’ 
High rate of follow-
up according to n’s 
cited in Table 1. 
Low drop-out rate 
(6%).  No 
description of 
missing data across 
measures. 
Unclear 
specification of 
primary and 
secondary 
outcomes, hence 
difficult to 
determine. 
 
Unclear how 
participants were 
selected (ie 96 out 
of 337) - additional 
selection bias? 
 
‘A total of 1,082 
Chinese patients 
Insufficient 
information to 
judge risk of bias. 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
explanation of the 
study, the 
participants were 
assigned randomly 
to receive usual 
care or the MBPP 
plus usual care.’ (p 
377)  
 
 
therapeutic 
interventions. 
 
However, no 
description of 
procedures utilised 
to protect the 
blind, report 
unblindings, or 
actions taken in the 
event of an 
unblinding. 
 “This trial was 
designed to test 
the effects of a 
mindfulness-based 
psychoeducation 
program (MBPP) 
for Chinese 
patients with 
schizophrenia on 
their symptom 
severity, illness 
insight, and 
psychosocial 
functioning. “ (p 
376) 
 
Then later 
 
“Based on recent 
psychoeducation 
studies (2,6,7), this 
sample size was 
required to detect 
any significant 
difference between 
the groups with 
repeated measures 
at a 5% significance 
level with a power 
of 90% and 25% 
with schizophrenia 
who were 
attending three 
outpatient clinics 
were eligible for 
the study, and 337 
(31%) agreed to 
participate. Of 
these, 96 (29%) 
were randomly 
selected for 
participation. No 
significant 
differences in 
socio- demographic 
characteristics 
were found 
between the study 
groups and the 241 
nonparticipants.’ 
(p377) 
 
No assessment of 
other variables, e.g. 
past treatment 
history/pre-
experience with 
mindfulness. 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
potential attrition 
(10). “ (p  377) 
 
Then later still 
 
“MBPP was tested 
for effectiveness 
with patients 
whose 
schizophrenia had 
endured less than 
five years, with the 
goal of reducing 
the likelihood of 
relapse or further 
psychotic 
episodes.” (p 377) 
 
Also not clear how 
hospitalisation data 
were collected. 
 
Chien & 
Thompson 
(2014) 
 
Low Low Low Unclear Low Unclear Low Low 
Simple 
Randomisation 
 
‘After giving their 
written consent, 
patients were 
asked to draw a 
Simple 
randomisation by 
sealed envelope. 
 
Rated as low due to 
lack of relevance of 
this criteria in this 
context given the 
nature of trials 
assessing the 
effectiveness of 
‘An independent 
trained research 
nurse performed 
the outcome 
measurements 
using a set of 
questionnaires 
Good follow-up All outcomes 
clearly reported 
however not 
reported according 
to original Clinical 
Trials. Gov protocol 
Pre-randomisation 
selection. 
 
‘Of approximately 
1085 eligible 
patients with 
schizophrenia (15% 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
sealed opaque 
envelope, in which 
a labelled number 
card indicated the 
group to which 
they were 
assigned.’  
 
psychological 
therapeutic 
interventions.  
 
before treatment 
allocation (Time 1), 
at 1 week (Time 2), 
12 months (Time 3) 
and 24 months 
(Time 4) following 
the 6-month 
interventions. Both 
the assessor and 
clinic staff were 
masked to 
treatment 
allocation. ‘ 
 
Breaks to blindness 
not reported, 
methods of 
concealment not 
reported. 
 
of this patient 
population) 
attending three 
out-patient clinics 
in the largest 
geographical region 
(New Territories) of 
Hong Kong, 515 
(48%) were 
successfully 
contacted. Of 
these, 450 (87%) 
agreed to 
participate and 107 
(24%) were then 
randomly selected.’  
 
‘From each clinic, 
those eligible 
patients who 
agreed to 
participate were 
listed in 
alphabetical order 
and then selected 
randomly from the 
list (n = 35–36 per 
clinic), using a 
computer-
generated random 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
numbers table.’  
 
 
Gaudiano & 
Herbert (2006) 
 
 
Unclear High Low High Low High High High 
Used 
randomization, 
however, method 
not clearly 
described 
 
‘Simple 
randomization 
without blocking or 
stratification based 
on a computer 
generated list was 
used without 
concealment.’  
 
 
‘Simple 
randomization 
without blocking or 
stratification based 
on a computer 
generated list was 
used without 
concealment.’  
 
Rated as low due to 
lack of relevance of 
this criteria in this 
context given the 
nature of trials 
assessing the 
effectiveness of 
psychological 
therapeutic 
interventions.  
 
Raters were not 
blinded 
 
‘Assessors and staff 
were not blind to 
treatment 
allocation’ (p 431). 
+ ‘therapist at 
times also acted as 
the assessor at 
post-treatment in 
both conditions.’(p 
432) 
 
 
40 randomised and 
29 analysed at end 
of treatment (>25% 
attrition) MVA 
conducted to 
evaluate missing-
ness. 
 
Intent-to-treat (ITT) 
analyses also were 
conducted to 
examine the 
reliability of 
completer 
analyses. Using 
SPSS Missing Value 
Analysis software. 
 
40 randomised, 38 
complete 
treatment, 29 
completers. 
Some reasons for 
loss of participants 
were stated: ‘Of 
the 38 participants 
It was hypothesized 
that the ACT group 
would show greater 
improvement on 
symptom measures 
at post-treatment 
and decreased 
rehospitalization 
rates at follow-up. 
Also, exploratory 
analyses were 
conducted to 
examine 
theoretically 
derived correlates 
of symptom 
change.  
 
Selective reporting 
of psychotic 
symptom measures 
particularly 
hallucinations 
distress. 
Gender differences 
emerged between 
groups and gender 
was related to 
relationships and 
BPRS measures 
(e.g. differences in 
type and severity of 
psychiatric 
symptoms). ACT 
group also had 
higher BPRS affect 
measures. No table 
presenting social 
and demographic 
characteristics of 
samples.  
 
Small sample size 
 
# of ACT sessions 
limited (3) and 
varied (determined 
by participants 
lengths of stay) as 
such protocol 
Due to high risk of 
selection, 
detection, and 
other bias. 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
who completed 
treatment, post-
treatment data 
were missing for 
nine participants 
due to their 
unexpected 
discharge from the 
unit before 
completing the 
assessments. One 
participant later 
withdrew from the 
ACT condition and 
one from the ETAU 
condition. 
Therefore, post- 
treatment 
completer analyses 
were conducted on 
the remaining 15 
participants in the 
ETAU condition and 
14 participants in 
the ACT condition.’ 
(p 424/425) 
 
 
 
feasibility cannot 
be determined or 
overall effect 
reliably stated 
 
Outcome 
measures: some 
are self-raters and 
done in front of 
assessor who is 
also therapist – 
social desirability 
effect? 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
 
Langer et al. 
(2011) 
 
Unclear Unclear Low Unclear High High High High 
Randomly 
allocated, however 
procedure not 
described, hence 
uncertain how 
effective. 
 
 ‘Twenty-three 
patients meeting 
the above criteria 
were selected to 
participate; 12 
were randomly 
assigned to the 
control group and 
the other 11 to the 
experimental 
group.’ (p 2)   
 
Insufficient 
information/not 
specified   
Rated as low due to 
lack of relevance of 
this criteria in this 
context given the 
nature of trials 
assessing the 
effectiveness of 
psychological 
therapeutic 
interventions.  
 
Insufficient 
information 
regarding 
procedure and 
effectiveness of 
blinding. 
 
‘clinician who 
conducted the 
assessment 
was blind to which 
group participants 
belonged, and 
independent of the 
MBCT therapist’. (p 
3)  
 
 
High attrition rate 
from intervention 
(36%): Final sample 
consisted of 7 
participants in the 
experimental group 
the control group. 
 
‘Two participants in 
the experimental 
group withdrew 
from the study. The 
first withdrew after 
the second session, 
saying he saw no 
benefit in the 
meditation. The 
second withdrew 
after the sixth 
session and, 
when contacted 
by telephone 
about his 
departure, 
remarked that he 
wanted a rest 
from El Timón 
(and therefore the 
group therapy 
Poor presentation 
of data. 
 
Outcomes are not 
stated explicitly at 
the beginning but 
then two of the 
used measures are 
not specifically 
reported 
on/included in 
discussion or 
conclusions. 
 
Very small sample, 
highly selective 
(both AG and JH) 
 
TAU not described 
 
No control of other 
variables, e.g. 
previous 
experience with 
mindfulness/PT 
treatment? 
 
No information 
about presenting 
problem, lengths or 
severity of illness 
etc. 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
they provided). 
Two other 
patients attended 
the sessions 
irregularly, less 
than 50% of the 
time, and were 
therefore excluded 
from the post-
treatment analysis. 
One participant in 
the control group 
did not wish to 
complete the 
questionnaires 
post-treatment.’(p 
2)  
 
 
Perich et al. 
(2013) 
 
 
Low Low Low Unclear High Low Low High 
‘Central 
randomization was 
conducted by an 
independent 
researcher who 
was not involved 
with the trial 
conducting the 
randomization 
process using a 
‘Assignment of 
treatment 
condition was 
concealed 
until after the 
baseline 
assessment 
interviews were 
completed.’ (p 336) 
 
Rated as low due to 
lack of relevance of 
this criteria in this 
context given the 
nature of trials 
assessing the 
effectiveness of 
psychological 
therapeutic 
interventions.  
‘Interview 
assessments of the 
YMRS and MADRS 
were conducted by 
an independent 
rater blind to the 
participant’s 
treatment 
allocation. Any 
material that may 
Attrition rate high 
(38%) = significant 
amount of missing 
data  
 
‘Fourteen 
participants (29%) 
(including 10 drop 
outs; see Fig. 1) did 
not complete the 
’An intention-to-
treat (ITT) analysis 
was conducted 
using the sample of 
95 participants who 
had enrolled in the 
study at baseline. 
Survival curves and 
relapse rates were 
assessed using the 
N/A Due to high 
attrition rate. 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
computer-
generated 
randomization list. 
A block design was 
used for 
randomization 
sequencing with 16 
participants in each 
block (eight per 
condition). The 
randomization 
sequence was 
created by a 
statistician not 
associated with the 
research study.’ (p. 
336) 
 
 have identified 
participant 
allocation was 
concealed.’ (p. 336) 
However, no 
description of 
procedures utilised 
to protect the 
blind, report 
unblindings, or 
actions taken in the 
event of an 
unblinding. 
 
MBCT condition 
requirements, and 
22 (47%) (including 
18 drop outs; see 
Fig. 1) did not 
complete TAU 
requirements’. (p. 
338) 
 
Reasons stated: 
MBCT: travel 
restrictions, too 
symptomatic, 
personal 
commitments 
TAU: Dissatisfaction 
with allocation, too 
symptomatic, 
conflicting work 
and personal 
commitments. 
 
 
Cox pro- portion 
hazard regressions 
model examining 
the time (weeks) to 
first recurrence 
during the 12-
month follow-up 
period using 
number of prior 
bipolar disorder 
episodes as a 
covariate in the 
model.’  
 
For the dimensional 
analyses, a mixed 
linear model (MLM) 
using the restricted 
maximum likeli- 
hood estimator 
(REML) was fitted 
in PAWS (44). The 
MLM allowed all 
available data to be 
used without 
excluding missing 
data. Furthermore, 
the MLM did not 
require the 
imputation of any 
  
 
98 
 
  
Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
data. The ITT 
analysis included 
an assessment of 
the primary and 
secondary outcome 
measures. 
Measurement 
points included 
pre-, mid-, and 
post-treatment and 
then 3-, 6-, 9-, and 
12-month follow-
up post-treatment.’  
 
 
Shawyer et al 
(2012) 
 
Low Low Low Low Low Low Low Low 
‘Randomization 
was by variable 
length blocks. 
Sequences of fixed 
length blocks were 
generated using 
the first random 
generator at 
www.randomizatio
n.com. Switching 
between blocks 
was determined by 
an additional 
random sequence 
‘Assignment of 
participants to 
conditions was 
undertaken by the 
study statistician 
who worked 
independently of 
staff involved in the 
recruitment, 
assessment and 
management of 
participants in the 
study.’ (p 3) 
 
Rated as low due to 
lack of relevance of 
this criteria in this 
context given the 
nature of trials 
assessing the 
effectiveness of 
psychological 
therapeutic 
interventions.  
 
‘Considerable 
efforts were made 
to ensure that the 
blindness of raters 
was maintained. 
Offices, data 
storage and travel 
logs of raters and 
therapists were 
kept separate and 
clinical staff and 
participants were 
regularly reminded 
not to divulge 
Low rates of 
incomplete 
outcome data. 
 
‘Attrition was low 
with only three 
participants 
withdrawing from 
the study. Two 
participants 
withdrew from 
Befriending after 
five and eight 
sessions 
All outcomes 
reported that were 
relevant and 
reasons for 
omission given.  
 
‘Compliance with 
harmful command 
hallucinations did 
not prove viable as 
an outcome 
measure. Although 
93% (40/43) of the 
sample had 
Good control of 
treatment integrity: 
‘An audit of a 
random sample of 
31 audiotaped 
therapy sessions 
was also 
undertaken by an 
independent 
auditor who was 
blind to all 
participant data 
and to the 
audiotape 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
generated by the 
same method. A 
similar procedure 
was used to 
generate 
assignments to 
treatments for 
participants initially 
assigned to the 
waitlist condition.’ 
(p. 3) 
 
details of their 
therapy to the 
raters. Raters were 
asked to classify 
participants into a 
treatment 
condition before 
and after each 
assessment and to 
indicate their level 
of confidence. All 
breaches in 
blindness were 
recorded and 
addressed by 
changing the rater 
wherever possible.’ 
(p 3) 
 
‘Breaches in 
blindness occurred 
on 22 occasions 
across the 97 
assessments where 
blindness was 
relevant. By 
changing the rater, 
corrective action 
was able to be 
taken in all but 5 of 
respectively. Both 
participants 
reported that 
intrusions or 
commands from 
auditory 
hallucinations 
contributed to the 
decision to 
withdraw. One of 
these participants 
also felt that his 
paranoia worsened 
as a result of the 
social contact. The 
third participant 
withdrew from 
TORCH after three 
sessions due to 
gaining work 
interstate. In 
addition to these 
withdrawals, two 
participants 
received fewer 
than 15 sessions. 
One TORCH 
participant 
received 12 
sessions and one 
experienced 
harmful commands 
in the past, only 
64% (25/39) of this 
group had ever 
complied and, at 
baseline, less than 
half the sample 
(18/43) had 
complied’.  
 
‘Our primary 
measures were 
therefore limited to 
confidence to resist 
obeying harmful 
commands and 
confidence in 
coping with 
commands’. (p 7) 
 
SHER outcomes 
omitted  
 
randomization 
procedure. Tape 
randomisation was 
stratified according 
to therapist, 
therapy (TORCH or 
Befriending), stage 
of individual 
therapy (early: 
sessions 1e8; late: 
sessions 9e15) and 
therapist 
experience (early vs 
late case). To 
assess the quality 
of TORCH sessions 
and confirm that 
Befriending 
sessions did not 
include TORCH 
techniques, 
sessions were rated 
using an adaptation 
of the Cognitive 
Therapy Scale for 
Psychosis (CTS-Psy -
Haddock et al., 
2001). [ ] A clinical 
psychologist (NT) 
who was blind to 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
these situations.’ (p 
7) 
 
Note: Raters 
guessed allocation: 
no longer 
recommended as a 
method to ensure 
blindness. 
 
Befriending 
participant 
received 9 sessions. 
It appeared that in 
both cases, difficult 
and chaotic 
personal 
circumstances 
reduced the 
motivation and 
ability to attend 
appointments.’ (p 
5) 
 
participant data 
and audiotape 
selection procedure 
performed the 
ratings and 
assigned each 
session to either 
the TORCH or 
Befriending group. 
The tape auditor 
was very 
experienced in CBT 
for psychosis and 
familiar with ACT. 
In addition, he 
received 
approximately 7 h 
training on the 
measures and the 
TORCH and 
Befriending 
treatments.’ (p 5) 
 
 
Van Dijk et al. 
(2013) 
 
Unclear Low Low Unclear Unclear Low High High 
Randomized, using 
manual 
procedure/simple 
randomization 
 
’Once consent was 
obtained and 
baseline data 
collected from 26 
patients, they were 
Rated as low due to 
lack of relevance of 
this criteria in this 
context given the 
nature of trials 
Not specifically 
stated 
 
It was implied, 
possibly: 
Attrition rate 
stated: 7% (12 of 
13 completed trial); 
86% of sessions 
were attended. 
All patients who 
were eligible to 
participate in the 
DBT group were 
randomized to 
Small sample size  
Group differences -
Control group was 
more depressed. 
 
Due to ‘unclear 
risk’ for  detection 
and attrition bias as 
well as high risk of 
other bias  
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
 
 
randomly assigned 
to intervention and 
control (wait-list) 
groups. Group 
assignments were 
placed in sealed 
envelopes by a 
hospital staff 
person who was 
not involved in the 
study. Study 
identification 
numbers were 
assigned and 
recorded on the 
master list, which 
was kept separate 
from consents and 
completed 
questionnaires to 
ensure that data 
would remain 
anonymous; and 
data were 
considered to be 
confidential.’ (p 
387) 
 
assessing the 
effectiveness of 
psychological 
therapeutic 
interventions.  
 
 
‘Study 
identification 
numbers were 
assigned and 
recorded on the 
master list, which 
was kept separate 
from consents and 
completed 
questionnaires to 
ensure that data 
would remain 
anonymous; and 
data were 
considered to be 
confidential.’ (p 
387) 
 
‘Data were 
extracted by the 
group facilitator 
and entered into 
SPSS 17.0 by a 
researcher using 
study identification 
numbers; no 
identifying 
information was 
reviewed or 
However: 
No reasons for 
either weren’t 
stated; 
No CONSORT 
reported; 
No df for main 
analyses reported 
 
enter the group 
immediately 
(intervention 
group) or to wait 
12 weeks until the 
next group (wait-
list control). In this 
way, all patients 
had the 
opportunity to 
participate in the 
group intervention. 
Given the small 
number of patients 
(13 assigned per 
group; 12 per 
group completed 
questionnaires and 
completed the 
study), secondary 
analysis was 
conducted using an 
additional 56 
patients who 
completed the BDG 
(total n 1⁄4 75) to 
increase study 
power and allow 
for confirmation of 
the RCT results 
‘Randomization to 
intervention and 
control groups 
resulted in similar 
groups except for 
mean scores on the 
BDI-II (see Table 3). 
Subjects in the 
control group 
reported higher 
scores or greater 
depression 
compared to the 
intervention group 
t = -2.2, p = .038).’ 
(p389) – however, 
this was controlled 
for (p 390) 
 
 
 
  
 
102 
 
  
Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
entered by the 
researcher.’ (p 387) 
 
But: who collected 
post-data? Not 
stated.  
 
 
White et al. 
(2011) 
 
Rated by JH only 
Low Low Low Low Low Low High Low 
‘Once baseline 
assessments had 
been completed, 
participant details 
were passed to AG 
who undertook 
computerised 
randomisation 
using a 
predetermined 
schedule of 
permuted blocks of 
random size. The 
research therapist 
then 
communicated the 
outcome of 
randomisation to 
each participant 
schedule of 
permuted blocks of 
random size’ (p 3) 
Following 
randomization ‘the 
research therapist 
then 
communicated the 
outcome of 
randomisation to 
each participant.’ 
(p 3) 
Rated as low due to 
lack of relevance of 
this criteria in this 
context given the 
nature of trials 
assessing the 
effectiveness of 
psychological 
therapeutic 
interventions.  
 
‘Participants 
completed 
assessment 
measures with a 
Research Assistant.’ 
‘Participants met 
with a researcher 
(JMcT, LR, and 
DMcC) on a 
monthly basis to 
complete the self-
report general 
outcome and 
therapy-specific 
measures. The 
assessors were all 
blind to treatment 
allocation.’ (p 3) 
 
‘Overall, blindness 
was breached on 9 
occasions (n = 7 for 
Total: 11% (ie 3 
participants, all 
from TAU) – 
reasons not stated  
 
Attrition rate was 
low – acceptable 
amount outcome 
data available 
 
No obvious 
omissions or 
selective reporting 
Small sample size 
 
No use of 
diagnostic 
interview 
 
Receipt of 
psychological 
intervention for 
some – not 
checked/controlled 
for  
 
Small sample size is 
an issue, but 
acceptable as 
feasibility study 
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Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection bias) 
 
 
Blinding of 
participants and 
personnel 
(performance bias) 
 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
 
Selective reporting 
(reporting bias) 
 
 
Other bias 
 
 
Overall risk 
 the ACT arm; n =2 
for the TAU arm) 
during the trial. For 
all but 
two of these 
individuals, further 
follow-up 
assessments were 
completed by 
another researcher 
who remained 
blind to allocation.’ 
(p 3) 
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APPENDIX 2: – Major Research Project 
 
Appendix 2.1: Guidelines for submission to Qualitative Research Journal  
 
QUALITATIVE RESEARCH JOURNAL – Author guidelines 
For full information see: 
http://www.emeraldgrouppublishing.com/products/journals/author_guidelines.htm?id=qrj 
 
Manuscript requirements 
Please prepare your manuscript before submission, using the following guidelines: 
Article Title A title of not more than eight words should be provided. 
Structured 
Abstract 
Authors must supply a structured abstract on the Article Title Page, set out 
under 4-7 sub-headings  
Maximum is 250 words in total (including keywords and article 
classification, see below). 
Headings Headings must be concise, with a clear indication of the distinction 
between the hierarchy of headings.  
 
The preferred format is for first level headings to be presented in bold 
format and subsequent sub-headings to be presented in medium italics. 
References References to other publications must be in Harvard style and carefully 
checked for completeness, accuracy and consistency. This is very important 
in an electronic environment because it enables your readers to exploit the 
Reference Linking facility on the database and link back to the works you 
have cited through CrossRef. 
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Appendix 2.2: Evidence of Ethical Approval 
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Appendix 2.3: Evidence of R&D Management Approval 
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Appendix 2.4: Participant Information Sheet and Consent Forms 
 
Appendix 2.4.1: Staff Participant Information Sheet 
 
 
 
Compassionate Recovery: Individualised Support in Early Psychosis (CRISP) 
Participant Information Sheet (Clinical Staff: Version 1, 23rd July 2012) 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please take time 
to read the following information sheet carefully and discuss it with others if you wish. We 
advise that you take at least 24 hours to decide whether to take part in the study. 
What is the research about? 
This study will attempt to explore the experience that staff have had in the implementation 
of formulation   as part of an Integrated Care Pathway. 
Who is being asked to take part? 
Clinical staff working within Esteem First Episode Psychosis Service will be invited to take 
part. 
Why have I been asked to take part? 
You have been asked to take part because you are currently working within Esteem First 
Episode Psychosis Service and have direct clinical experience of using Compassion Focussed 
Recovery interventions. 
Do I have to take part? 
No. Taking part is entirely up to you. If you do participate you are free to terminate 
involvement at any time without giving a reason and without your decision impacting in 
any way with the research team or your employer. 
What would be involved? 
 You will be asked to sign a consent form prior to taking part in the study and will be 
provided with a copy of this. You would then arrange to meet with the research nurse on 
an individual basis at a venue of your choice. 
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Next two semi-structured interviews exploring your experiences will be conducted. These 
will last for approximately 45minutes to one hour each. There is flexibility in the content of 
the semi-structured interview so that you can discuss issues of particular relevance to you.  
Interviews will be audio recorded, transcribed into print and then analysed by the research 
team. You will receive a copy of the transcription and of the researchers’ analysis of the 
interview so that you will be able to provide verbal and/or written comments on this. 
Will I be identifiable in the transcription discussion or in any verbal or written report? 
No. You will not be personally identifiable in the typed transcription (you will be given a 
pseudonym) or in any subsequent written account. The audio recordings will not be heard 
by anyone other than the transcribers and University of Glasgow research staff.  All audio 
recordings will be stored securely in locked premises and on password protected 
computers. Audio recordings will be destroyed following transcription of the study. 
Are there any risks or benefits to taking part? 
The study is attempting to evaluate the impact of introducing formulation within an 
Integrated Care Pathway from a staff perspective. We hope that the information you 
provide will help us to improve the experience for staff and inform us about any changes 
that may be required for the future. 
There is not anticipated to be any adverse effects from participating in this research.  
What will happen to the results of the study? 
Once the study is completed we will produce a report that will describe the findings of the 
study. We will aim to disseminate the report to professionals by submitting the report for 
publication in professional and academic journals. We will also present the findings to 
Esteem First Episode Psychosis Service staff through a feedback event. 
Who is organising and funding the research? 
The University of Glasgow and NHS Greater Glasgow & Clyde will organise the research.  
Funding is already in place provided by the Scottish Government’s Chief Scientist Office. 
Who has reviewed the study? 
The study has been reviewed by the University of Glasgow to ensure that it meets 
standards of scientific conduct. It has also been reviewed by the Chief Scientist Office to 
determine whether it was suitable to receive Scottish Government funding. The West of 
Scotland Research Ethics Committee 3 has also reviewed the study to ensure that it meets 
standards of ethical conduct. 
Can I speak to someone who is independent of the study? 
Yes you can. Professor Tom McMillan who is not involved in the study can answer 
questions or give advice. His telephone number is 0141 211 3920. 
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What if I want to make a complaint? 
If you want to make a complaint about any aspect of this study, please contact: 
Professor Andrew Gumley 
Mental Health & Wellbeing 
University of Glasgow 
Admin Building 
Gartnavel Royal Hospital, 
1055 Great Western Road 
Glasgow G12 0XH 
0141-211-3927 
  
  
 
117 
 
Appendix 2.4.2: Staff Participant Consent Form 
 
 
Staff Participant Identification Number: ____ 
Staff Participant Consent Form (Version 1, 23/07/2012) 
 
Title of Project: Compassionate Recovery: Individualised Support in Early Psychosis (CR: 
ISP) 
                                                                                                                                       Please Initial 
Box 
1. I confirm that I have read and understand the information sheet dated....................  
(version 1, 23/07/2012) for the above study. I have had the opportunity to consider the,  
 information, ask questions and have had these answered satisfactorily.  
 
2.  I understand that my participation is voluntary and that I am free to withdraw at any time  
without giving any reason, without any effect  on my employment. 
 
3. I agree to take part in a qualitative interview exploring my experiences of   
            formulation as part of an Integrated Care Pathway. 
      
 
4.  I agree that this interview can be audio recorded and transcribed. 
 
5.  I agree to review my completed transcription report and provide comments as appropriate to 
            the research team so that any amendments can be made. 
 
 
6.          I agree to my transcribed data being stored for up to 5 years and used for further data analysis. 
 
 
_____________________   ________________  __________________________  
Name of Staff Participant   Date   Signature  
 
--------------------------------------             ----------             ------------------------------------- 
Name of research staff taking consent.         Date                    Signature 
 
When completed, 1 for participant; Original to be retained in research site file; 
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Appendix 2.4.3: Service-user participant information sheet 
                                  
Compassionate Recovery: Individualised Support in early Psychosis (CR:ISP) 
Contact: 
Professor Andrew Gumley 
Academic Unit of Mental Health and Wellbeing, 
University of Glasgow, 
Gartnavel Royal Hospital, 
Academic Centre, 
University of Glasgow, 
Glasgow G12 0XH 
0141 211 3927 
Participant Information Sheet (Version 2, 17th June 2011) 
You are being invited to take part in a research study. Before you decide it is important for you to understand 
why the research is being done and what it will involve.  Please take time to read the following information 
carefully and discuss it with others if you wish. We advise that you take at least 24 hours to decide whether to 
take part in the study.  
What is the research about? 
In an earlier study of recovery amongst service users of the ESTEEM First Episode Psychosis Service we found 
that many service users experience a very large improvement in their mood (e.g. feeling depressed) and their 
symptoms (e.g. hearing voices and feeling suspicious and paranoid). This occurred within six months of contact 
with our service. We found that a smaller proportion of service users experienced some delay in their recovery 
and this was reflected in problems such as being withdrawn from others, not having pleasure from activities 
and finding day to day tasks a problem. We discovered that one important potential cause of this delay in 
recovery was a poorer quality of relationship between the service user and the service. 
We want to improve outcome for all our service users and therefore we are implementing an Integrated Care 
Pathway to ensure that your needs are routinely and carefully assessed regularly throughout your journey of 
recovery after your first contact with ESTEEM. Our Integrated Care Pathway has been designed to ensure that 
we regularly assess your symptoms (e.g. hearing voices, feeling suspicious etc), your mood (feeling depressed), 
your use of alcohol and drugs, the quality of your recovery (how you feel about your recovery in terms of valued 
activities and relationships) and the quality of your relationship with the service. These assessments ensure that 
we can work with you to get the right combination of help for you, in a way that is tailored to you at the most 
appropriate time in your journey of recovery. 
Who is being asked to take part? 
We are asking all service users who are supported by ESTEEM to consent to take part in this study. 
Why have I been asked to take part? 
You have been asked to take part because you are being currently supported by the ESTEEM First Episode 
Psychosis Service. 
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Do I have to take part? 
                                  
Do I need to take part? 
No. Taking part is entirely up to you. If you do not wish to take part it will not affect any treatment that you 
currently receive. Also, if you do decide to take part, you are able to change your mind and withdraw from the 
study at any time without it affecting your care either now or in the future. 
What will happen next if I want to take part? 
If you decide to take part in the study after reading this information sheet and after you have your questions 
answered by the researcher, the researcher will confirm that you wish to take part and arrange to complete a 
consent form.  We are going to ask you to consent to three things. 
1. You will be asked to consent to the research team using data taken from routinely collected assessments, 
which are conducted as part of the ESTEEM Integrated Care Pathway. This will involve our researcher having 
access to your casenotes. 
2. You will be asked to consent to being approached to participate in an interview exploring your experiences of 
recovery. This is an optional aspect of the research. The interview will last about an hour and will explore your 
experiences of recovery and your experiences of the ESTEEM service.  
Since the interview will explore your experiences of recovery it will therefore cover events and feelings that are 
potentially emotionally upsetting. You do not have to talk about these experiences if you do not want to. 
Participation in this aspect of the study is optional.  
The interview will be recorded and transcribed. After your interview has been transcribed we will destroy the 
recording and ensure that any personal details contained within the transcription of the interview will be 
removed. We will use quotations in subsequent reports and publications but it will not be possible to identify 
you through these. 
3. You will be asked your consent to approach a person (e.g. family member) who is most closely involved in 
supporting you on a day to day basis in your recovery. We are keen to explore their experiences of supporting 
you and their experiences of the ESTEEM service. Participation in this aspect of the study is optional.  
Are there any risks or benefits to taking part? 
The study is evaluating the impact of introducing an Integrated Care Pathway to improve outcomes for all 
service users who are seen by the ESTEEM service. We hope that the research will be of benefit to you by 
improving the service you receive. There is a possibility that talking about some of these issues in the interview 
may be emotionally upsetting. 
What about confidentiality? 
Yes.  The information you provide us with will be treated confidentially.  All recordings and transcriptions will be 
stored on a password-protected computer.  Your name and any information that could identify you will not 
appear in any reports. With permission from you, your GP will be informed that you are taking part in the study.    
If you share information that makes the research team concerned for your safety or the safety of other people, 
we may be required to tell others involved in your care (e.g. your key-worker or psychiatrist).  We will always 
notify you beforehand if we are going to do this, and explain why.   
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What will happen to the results of the study? 
Once the study is completed we will produce a report that will describe the findings of the study. You will not 
be identified in any report or publication. The report will not include any personal details of the people who 
took part; it will only describe what happened to the groups of people who received different types of 
treatment. 
Who is organising and funding the research? 
The University of Glasgow and NHS Greater Glasgow & Clyde will organise the research. The Scottish 
Government’s Chief Scientist Office will fund the study. 
Who has reviewed the study? 
The study has been reviewed by the University of Glasgow to ensure that it meets standards of scientific 
conduct. It has also been reviewed by the Chief Scientist Office to determine whether it was suitable to receive 
Scottish Government funding. West of Scotland Research Ethics Committee 3 has also reviewed the study to 
ensure that it meets standards of ethical conduct.   
Can I speak to someone who is independent of the study? 
Yes you can. Professor Tom McMillan who is not involved in the study can answer questions or give advice. His 
telephone number is 0141 211 3920. 
What if I want to make a complaint? 
If you want to complain about any aspect of this study, please contact: 
 
Professor Andrew Gumley 
Academic Unit of Mental Health and Wellbeing, 
University of Glasgow, 
Gartnavel Royal Hospital, 
Academic Centre, 
University of Glasgow, 
Glasgow G12 0XH 
0141 211 3927 
 
The NHS complaints system is also available at 0141 201 4500. 
Thank you. 
 
  
  
 
121 
 
Appendix 2.4.4: Service-user participant consent form 
 
 
 
 
PARTICIPANT CONSENT FORM (Version 2: 17
th
 June 2011)  
 
Title of Study:  Compassionate Recovery: Individualised Support in early Psychosis 
(CR:ISP) 
 
Contact Address: Academic Unit of Mental Health and Wellbeing, Academic Centre, Gartnavel 
Royal Hospital, 1055 Great Western Road, Glasgow, G12 0XH  
 Please Initial 
Box  
 
1. I confirm that I have read and understood the information sheet about the study dated 17/06/11 
(Version 2) 
 
2. I confirm that I have had an opportunity to consider the information, ask questions about the study, 
and have had these answered satisfactorily. 
 
3. I understand that my participation in the study is voluntary and that I am free to withdraw from the 
study at any time, without giving any reason, and without my medical care or legal rights being 
affected.  
 
The following items are core: If you do not consent to all of these, then we regret we cannot include 
you in the study. I consent to: 
 
4. I give consent for the research team to have access to my case notes, solely for the purposes of the 
research study described in the Participant Information Sheet dated 17/06/11 (Version 2) 
 
5. Having the information that I provide as part of my routine care stored on a confidential electronic 
database, to which investigators and responsible individuals from the research team and representatives 
of the Sponsor (NHS Greater Glasgow & Clyde) will have access (with the proper approvals) for 
research and quality assurance purposes. 
  
The following items are optional. You can take part even if you do not consent to these. I consent to: 
 
5. Taking part in a qualitative interview exploring my experiences of recovery and of the ESTEEM 
service 
 
6. That this interview will be recorded and transcribed. Following transcription the original recording 
will be destroyed and all personal data removed from the transcription 
 
7. I understand that it may be difficult or upsetting to talk about my experience of recovery, and that 
I will have access to professional support if this is required.   
 
8. That a member of the research team can contact the person most involved in supporting me on a 
day to day basis named …………………………………..[INSERT NAME HERE] 
 
9. I agree for my GP to be informed of my participation in the above study.  
 
10. Being contacted in the future by a member of the CR:ISP team to discuss possible participation in 
further research arising from this study. I affirm that this will not commit me in any way to taking 
part in further research. 
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_____________________  ________________  __________________________  
Name of Participant    Date    Signature  
 
 
_____________________  ________________  __________________________  
Name of Person taking consent  Date    Signature  
 
 
When completed, original to be kept in case notes.  Copies for participant and researcher file. 
 
Thank you for taking part in the study. 
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Appendix 2.5: Interview Schedules  
 
2.5.1. Interview schedule Phase 1 – Clinical Psychologists   
 
Preamble: 
Thank you very much for taking the time to meet with me today. As you know I’m 
interested to explore with you, your experiences of multidisciplinary (MDT) case 
formulation in the context of the ESTEEM service. I will be particularly interested to explore 
your experiences in developing case formulation, the benefits of this and the challenges 
this creates for your role in the service. As part of the qualitative interview process I will be 
digitally recording this interview in order for me to transcribe it later.  Any information 
pertaining to you such as your name or the names of others will be fully annonymised at 
this stage. I will use quotations to illustrate important themes emerging in the research but 
you will not be identifiable through them in any reports or publications. The interview will 
take around 45 minutes but should you wish to stop for any reason or take a break please 
do not hesitate to let me know. 
 
Have you any questions before we begin? 
 
1. Tell me about your role in the service? 
 
 
2. Tell me about your experience using case formulation with the clinical team? 
 
Probe: - Team-based formulation (5 P’s; Compassionate Reformulation)  
 - Working with individual member of staff 
 
 
3. What have been the strengths of MDT formulation? 
 
 
4. What have been the challenges of MDT formulation? 
 
 
5. How do you see MDT formulation develop over time? 
 
 
Example Probe, follow-up questions: 
 
a) Can you give me an example of that? 
b) Can you describe the situation? 
c) How did you deal with that? 
d) How did others respond? 
e) What was the outcome? 
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2.5.2. Interview schedule Phase 2 - non-psychology MDT staff 
 
Preamble 
Thank you very much for taking the time to meet with me today. As you know I’m 
interested to explore with you, your experiences of multidisciplinary (MDT) case 
formulation in the context of the ESTEEM service. I will be particularly interested to explore 
your experiences in developing case formulation within the team, and your view of case 
formulation more generally, with regards to benefits of this and the challenges it creates 
for your role in the service. As I said, I’m interested in your experience with and view of 
case formulation not your knowledge of it.  
 
Any information that you are sharing with me is confidential and will only be shared with 
people directly involved in this research project. As part of the qualitative interview process 
I will be digitally recording this interview in order for me to transcribe it later. Any 
information pertaining to you, such as your name or the names of others, will be fully 
anonymised at this stage. I will use quotations to illustrate important themes emerging in 
the research but you will not be identifiable through them in any reports or publications. 
The recording will be deleted once the study is completed.  
 
The interview usually takes around 45 minutes but should you wish to stop for any reason 
or take a break at any point please do not hesitate to let me know. How much time do you 
have available today? Have you got any questions before we begin?  
 
1. Tell me about yourself. 
Probe:  
 Job 
 Length of time in the service 
 
2. Tell me about your experiences of case formulation within the service. 
 Probe:  
 Doing a formulation of one of your cases. 
 Taking part in formulating other keyworker’s cases. 
 
3. How is formulation helpful? 
Probe: 
 What does it do? 
 In what way? 
 What facilitates helpful formulation? 
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4. Can formulation be unhelpful? 
Probe: 
 What hinders the process of formulation? 
 
5. How do you see your role in formulation? 
 
6. What suggestions do you have about doing case formulations in teams in 
the future? 
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2.5.3. Interview schedule Phase 3 - Service-users 
 
Preamble 
Thank you very much for being one of the people that have agreed to meet with me for this 
part of the study. Thank you for taking the time! As you know, I’m from the University of 
Glasgow and I’m interested to hear about your experiences with the Esteem service. I will 
be particularly interested to explore with you your experiences of the care and support you 
received/are receiving. It is not about you rating the service, but telling me about your 
experiences with it. Everything that you tell me is confidential and will not be shared with 
anyone outside the research team. It will not be fed back to the service and/or individual 
staff members at Esteem.  Have you got any concerns about this? 
As part of the qualitative interview process I will be digitally recording this interview in 
order for me to transcribe it later.  Any information pertaining to you such as your name or 
the names of others will be fully anonymised at this stage. I will use quotations to illustrate 
important themes emerging in the research but you will not be identifiable through them in 
any reports or publications. This recording will be deleted once the study is completed. Is 
that ok with you? 
The interview takes around 45 minutes but should you wish to stop for any reason or take a 
break at any point please do not hesitate to let me know. How are you doing today? Do you 
think you’ll be ok with 45 minutes? How much time do you have available today? Have you 
any questions before we begin? 
1. Can you tell me a little bit about yourself? 
- When were you first seen by ESTEEM? 
- Who do you see and how often? 
 
2. Can you tell me about the help you receive from ESTEEM?  
- What kinds of difficulties have you sought help for? 
- What has changed for you over time? / What has gotten better for you 
over time?  
 
3. How would you describe your relationship with Esteem? 
- What support do you receive? 
- With whom do you work? 
- Do you feel you’re working together? 
- Do you agree about what help/support/assistance or care plan is needed 
and what is currently in place/currently being done?  
 
4. Do you have any suggestions to give to the service? 
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Appendix 2.6: Major Research Project Proposal 
Major Research Project Proposal 
Title 
Shared understanding – Exploring experiences of case formulation from multiple 
perspectives within the context of an early intervention service  
 
Abstract 
Case formulation is seen as central to psychological interventions by a range of 
professionals, and its use supported by good-practice guidelines (e.g. British Psychological 
Society, 2010). Increasingly, multidisciplinary teams (MDT) are adopting a formulation-
based approach to allow for more consistent and effective care. However, the research 
evidence-base for formulation is limited. There have been some qualitative studies 
exploring the use of formulation within teams by interviewing members of staff. However, 
the process of developing formulations is complex, requiring collaboration between staff, 
service-users and family members. The overall aim of this study therefore is to explore 
experiences of case formulation from various perspectives in the context of an early 
intervention service. It is proposed that grounded theory would allow for the flexibility and 
openness needed to explore individual’s experiences in depth, while bringing everyone’s 
views together within theory emerging. Taking a staged approach, interviews would be 
conducted with clinical psychologists, psychiatrists, mental health staff, service-users and 
families. Constant comparison between the data sets and active involvement of a local 
steering group is hoped to enhance methodological credibility and sensitivity to context. 
This study would have the potential to increase understanding of the value of team 
formulation to improve outcomes for service-users.  
 
Introduction 
Formulation has been recognized as central to the implementation of psychological 
interventions since the emergence of the scientist-practitioner model in the 1960s (Butler, 
1998). It is a skill increasingly valued by a range of professionals within psychiatry, 
psychology, psychotherapy and counselling. Definitions of ‘formulation’ vary to some 
degree, depending on professional background and therapeutic approach. In short, it can 
be summarized as a ‘hypothesis about a person’s difficulties, which draws from 
psychological theory’ (Johnstone & Dallos, 2006). Eells (2007) defined formulation as ‘a way 
of making sense of an individual’s psychological, interpersonal, emotional and behavioural 
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difficulties by examining and linking a broad range of biopsychosocial influences, drawing 
from empirical evidence and theory, and considering causes, precipitants and maintaining 
factors’. This then allows for a more tailored, individualized approach to treatment as 
opposed to a standardized one based on diagnostic categories (Aston, 2009). It has been 
argued that a good formulation not only enhances the understanding of an individual’s 
current difficulties, but also helps predict potential challenges to intervention, for example 
by facilitating understanding service-users’ ability to build and maintain therapeutic 
alliances and engage with services (Sturmey, 2009).  In practice, formulation is an on-going 
process that arises from assessment and collaboration with service-users and teams. It is 
important for practitioners to be reflective throughout this process and to ensure that the 
developing formulation is an accurate and meaningful account of the service-user’s 
problem (Division of Clinical Psychology, DCP, 2011). Various professional bodies have 
identified psychological case formulation as a core professional competency for Clinical 
Psychologists (e.g. Health Professions Council, 2009; British Psychological Society, 2010; 
Division of Clinical Psychology, 2010).  
 
Increasingly, formulation is being used in teams, both in the community and inpatient 
settings. Good-practice guidelines support this trend by recommending a formulation-
based approach in multidisciplinary teams (MDT), with clinical psychologists taking an 
active role in promoting and facilitating this (DCP, 2011). Team formulation can enable 
shared understanding of an individual’s difficulties and resources for effective change, 
thereby allowing for a consistent, more effective team approach to intervention (Oynett, 
2007, in Christofides et al., 2011). For example, consideration of an individual’s attachment 
style can facilitate understanding of his or her help seeking style and ability to engage with 
services (Gumley et al., 2010). Incorporating this into a formulation can help teams to 
respond in a way that prevents disengagement, thus better support recovery. In addition, 
shared formulation can help team members to feel supported and contained, and can be 
invaluable for addressing and overcoming difficulties when working with complex and/or 
challenging cases (DCP, 2011). 
 
Despite the established use of formulation within psychological therapies, its promotion by 
professional bodies, and a general view of its benefits in MDT, the research evidence-base 
surrounding formulation is limited. This is both in terms of promoting shared 
understanding of service-users within teams as well as outcomes for the individual 
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(Johnstone & Dallos, 2006). The available evidence regarding individual use of formulation 
is inconclusive, and for use of formulation within MDT almost non-existent (Christofides et 
al., 2011). 
 
With regards to individual therapy, a few studies have compared manualized with 
individualised, formulation-driven therapeutic approaches in an attempt to determine the 
benefits of using formulation. For example, Jacobsen et al. (1989) compared manualized 
with individualised formats of behaviour therapy for couples and found a slightly better 
maintenance of improvements after six-months in the individualised group. Contrarily, 
other studies have found a superior effect of manualized approaches over individualised 
ones (e.g. Schulte et al., 1992; Emmelkamp et al., 1994). However, a weakness of these 
studies may be that internal processes of the therapists involved were not explored 
(Jacobsen et al., 1989). That is, experienced therapists may inadvertently have used 
formulation, even in the manualized intervention group. Chadwick et al. (2003) aimed to 
assess the impact of case formulation as part of CBT treatment of anxiety and depression in 
psychosis. For this purpose, measures of distress were compared pre- and post-
formulation-sharing, and therapists and service-users’ views of this process explored within 
semi-structured interviews. No significant effect was found with regards to levels of 
distress, and the qualitative data indicated mixed feelings about the usefulness of 
formulation in service-users, but positive ones in therapists. Interestingly, therapeutic 
alliance was rated to be affected positively by therapists but not by service-users. A 
subsequent study by Morberg Pain et al. (2008) highlighted the complexity around service-
users’ experience of formulation, with some exhibiting positive and others negative 
emotional reactions to the formulation process. These studies highlight some interesting 
aspects regarding experiences of formulation-sharing, e.g. possible differences in value of it 
for therapists and service-users. However, both studies treated case formulation as 
intervention per se, rather than viewing it as part of the essential pre-treatment stage. Yet, 
Dunn et al. (2011), investigating the effectiveness of CBT for psychosis (CBT-P) by assessing 
its component parts, concluded that only full therapy (consisting of assessment, 
formulation and active change methods in CBT-P) appears to lead to significant benefit and 
change for the service-user, not assessment and formulation (i.e. partial therapy) by itself.   
 
Studies addressing use of formulation within MDT have tended to evaluate its benefits and 
limitations by exploring staff perspectives. For example, Summers (2006) interviewed 25 
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staff of different disciplines (including psychiatrists, nurses, support workers and 
therapists), all working within the same team providing care for patients with severe 
mental illness on a ward of a high-dependency rehabilitation service. The results indicated 
that staff viewed formulations as valuable, helping them to gain a better understanding of 
their patients, which led to better care planning, staff-patient relationships, staff 
satisfaction and team working. Psychologists’ views were not obtained in this study. In 
another qualitative study, Christofides et al. (2011) interviewed 10 clinical psychologists 
about their experiences of using formulation within MDT and found similar results. Clinical 
psychologists felt that shared formulation allowed for more consistent and coordinated 
care and promoted reflectiveness and active peer support within teams.  
 
Overall, these studies offer valuable insight into staff perspectives about using formulation 
within MDT. Yet, they explore one particular point of view only, either that of staff more 
generally, or clinical psychologists more specifically. However, the process of formulation 
within MDT should be embedded in communication and interaction between staff of 
various disciplines, service-users and, if relevant, family/carers. Team formulation develops 
dynamically within the discourse taking place between these individuals and may be 
experienced differently from different perspectives. As such, exploring team formulation 
from only one perspective makes it difficult to fully grasp the complexity and benefits of 
this process overall, and to understand its value for the people involved in it individually. It 
therefore is difficult to draw conclusions about the value of MDT formulation overall. It 
appears that a comprehensive exploration of the process of team formulation requires the 
use of a methodological approach that actively promotes triangulation, thus allowing for 
the exploration of the perspectives of everyone involved in the process in a dynamic and 
flexible way.  
 
Point of departure  
The point of departure for the current study is to explore experiences of formulation from 
multiple perspectives including clinical psychologists, other mental health staff, service-
users and families in the context of an early intervention service. Given clinical 
psychologists’ active role in facilitating and guiding the process of team formulation this 
appears to be the most logical departure point for this type of exploration. From there, a 
stepped approach to qualitative enquiry will be taken that allows for the involvement of 
other key staff members, service-users and carers in a top-down, but dynamic and flexible 
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fashion. This in turn will allow for triangulation and the emergence of theory in a bottom-
up fashion, giving insight into the role of formulation in planning and organising MDT care. 
 
Method 
Grounded Theory methodology 
Grounded Theory (GT) is a qualitative method widely used. It may be defined as ‘the 
discovery of theory from data systematically obtained from social research’ (Glaser and 
Strauss 1967: 2). It allows for the discovery of meaning and underlying processes of a 
phenomenon by interpretatively considering each individual’s perspective. Given the 
subject of study, and consistent with previous qualitative work in recovery after psychosis 
(Boyd & Gumley, 2007; Svanberg, Gumley & Wilson, 2010), the use of a social construction 
version of GT (Charmaz, 2003) appears to be the most suitable methodology for exploring 
the topic of interest. This version has its roots in ‘social interactionism’ (Mead, 1934), which 
assumes that it is the meanings people give to situations which determine human 
behaviour. These meanings are influenced by history, culture and language, and actively 
constructed within social interactions, mediated by an interpretive process used by each 
person. Hence, meaning is to be viewed as a constructed process. As a result, GT arises 
from the interaction between researcher and participants – it is actively constructed, rather 
than representing an objective reality. The existence of a unidimensional external reality is 
not assumed (Charmaz 2000). 
 
To increase methodological rigour, credibility and utility, criteria for improving the quality 
of qualitative research would be considered in the design and implementation of the 
qualitative study (Walsh & Downe, 2006).  
 
Participants 
In order to meaningfully explore the aim stated above, it is proposed for the project to 
purposively sample clinical psychologists, key staff members (including psychiatrists, 
nursing staff, occupational therapists and support workers), service-users and their family 
members and/or carers. These will be recruited from the ESTEEM First Episode Psychosis 
Service in Glasgow, a service where MDT case formulation is central to clinical practice. 
Given the research approach, sample size need not be determined. Rather, data collection 
will continue until saturation of the topics emerging from the interviews, as required by a 
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GT approach, is reached. Inclusion criteria will require that all participants are or have been 
involved with ESTEEM, and are able to consent to and participate in the study. 
 
Sensitivity to context 
Relevant literature on use of MDT formulation will be reviewed in depth before 
commencing data collection, which will allow identifying gaps in knowledge. In line with the 
proposed methodology of GT, reviewed literature is not to form the basis of an emerging 
theory, but rather will serve as a guide for developing initial interview questions. Open 
discourse will be encouraged during the initial interviews to gain insight into participants 
perspective of using formulation for planning and organising care. A stepped/phased 
approach of data collection will ensure that interview questions remain flexible and are 
adapted to evolving theory. Such an approach further will allow the exploration of different 
perspectives from different groups, facilitating triangulation (see below).  
 
It is hoped that the project can be supported and actively guided by the existing Principal 
Investigators Steering Group (PI Steering Group), providing advice and feedback in terms of 
practical concerns and data analysis (e.g. the development of the semi-structured 
interview). This group is responsible for oversight and management of a wider CSO funded 
study of implementation of a novel Integrated Care Pathway for early psychosis (CZH/3/5, 
Compassionate Recovery: Individualised Support in early Psychosis (CR:ISP) Implementing 
improvement strategies based on an Integrated Care Pathway for Early Psychosis) and has 
been granted ethical approval (11/AL/0247) and managerial approval. Liaising with the PI 
Steering Group is hoped to ensure the project fits in with the social context it is meant to 
take place in, for example by advising on how to best go about interviewing the different 
participant groups.   
 
Health & Safety Issues (Researcher/Participant) 
Participants will be interviewed in clinic settings within an NHS service (i.e. ESTEEM). As 
such, existing local health and safety guidelines and procedures will be followed at all times 
to ensure participants’ and researcher’s wellbeing. Furthermore, staff on site (that know 
participants and researcher well) will be available for debriefing, emotional support and 
advice as required. Every attempt will be made to identify and minimise risk before and 
while participants are being interviewed. Refer to Health & Safety Form (Appendix 1) for 
more details. 
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Ethical Issues  
The project is part of a wider funded study (CSO, Compassionate Recovery: Individualised 
Support in early Psychosis (CR:ISP) Implementing improvement strategies based on an 
Integrated Care Pathway for Early Psychosis: CZH/3/5, Appendix 2) and has received ethical 
approval (11/AL/0247, Appendix 3) including the qualitative component described in this 
proposal. The protocol for this study is attached to demonstrate that this proposal builds 
significantly on the original description of the qualitative component (Appendix 4). We will 
inform the sponsor of the study (Dr Erica Packard, NHS Greater Glasgow & Clyde) of the 
interview development at each stage of the project and based on their advice we will apply 
any amendments to ethics as appropriate. 
 
Participation, as per Research Ethics and R&D approval, will be voluntary and informed. 
Informed consent will be obtained of all participants (see Information sheets and Consent 
Forms, Appendices 5, 6 and 7). Recruitment will be sensitive to avoid coercion. All data, 
verbal and written, will be treated in accordance with NHS Greater Glasgow & Clyde 
guidelines on data protection. Service-user and carer participants have already provided 
informed consent and have been advised about the potential use of anonymous quotations 
within the written report as well as the boundaries of confidentiality, determined by duty 
of care (refer to Appendix 6 and 7). Refer to Health & Safety form (Appendix 1) for more 
details. 
 
Procedure 
Data collection and analysis 
As outlined above, it is proposed for the data collection to proceed in four stages (or 
phases), whereby data analysis will follow each phase and inform the interview questions 
for the next phase (or group of participants). As such, the emerging theory will unfold 
dynamically and flexibly out of triangulation between the different data sets, thereby 
staying true to the spirit of GT. The following way of proceeding is proposed: 
Phase 1: 
Development of semi-structured interview questions (with guidance from steering group 
and supervisors). The researcher will then go on to conduct in-depth qualitative interviews 
with clinical psychologists, exploring experiences of formulation and reformulation. A 
particular focus on the role of case formulation in planning care, impact on psychologists 
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practice and on team practice may be a useful way to structure these interviews (See 
Appendix 8 for initial interview).Following transcription and qualitative analysis of the 
collected data, the results (i.e. emerging themes) are used to modify and inform the 
content and structure of the phase 2 interview, in collaboration with members of the 
existing PI Steering group.  
Phase 2 
In-depth interviews will be conducted with a purposive sample of staff exploring 
experiences of formulation and reformulation. A particular focus on the role of formulation 
in planning care and the impact on team and clinical practice may be a useful way to 
structure these interviews, however the outcome of the phase 1 analysis will be 
predominant in determining the content of the phase 2 interview. 
Following transcription and qualitative analysis of the collected data, the results 
(i.e. emerging themes) are used to modify and inform the content and structure of the 
phase 3 interview (based on phase 1 and 2 analyses), in collaboration with members of the 
existing PI Steering group.   
Phase 3 
In-depth interviews will be conducted with a purposive sample of service-user participants 
who have already given informed consent (See Appendix 6 for Participant Information 
Sheet and Consent Form). The content of the interviews will have arisen from phase 1 and 
phase 2 analyses, but a particular focus on exploring experiences of recovery is suggested. 
Following transcription and qualitative analysis of the collected data, the results 
(i.e. emerging themes) are used to modify and inform the content and structure of the 
phase 4 interview (based on phase 1, 2 and 3), in collaboration with members of the 
existing PI Steering group.   
Phase 4 
In-depth interviews will be conducted with family members/carers (See Appendix 7 for 
Participant Information Sheet and Consent Form). Interview contents and structure with be 
informed by phases 1, 2 and 3, but a particular focus on exploring experiences of recovery 
is suggested.  
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Data Analysis 
Following the principles of GT, the data analysis will start with line-by-line coding and the 
more significant and frequent codes emerging from this process are extracted. The use of 
constant comparative methods and memos written throughout the interpretative process 
will guide further theoretical sampling and help to raise the codes to conceptual categories. 
When categories are deemed to be coping adequately with new data, without requiring 
continual revision and when no new relationships or codes are emerging from the data 
analysis, the process of theory generation will have met ‘theoretical sufficiency’ (Dey, 
1999). The triangulation of the different views of service users, carers and professionals will 
be used to develop a more comprehensive understanding of the role of formulation within 
MDT through methods of constant comparison rather than as a measure of internal validity 
(Mays & Pope, 2000). GT will then be constructed as a synthesis of categories, memos and 
relationships between concepts noted in the process of data analysis.  
 
Settings and Equipment 
A suitable setting for data collection to take place may be at ESTEEM. Digital recording 
equipment will be used to record the interviews. An encrypted laptop will be used for 
transcription and storage of collected data.  
 
Financial Issues 
Equipment needed (digital recorder, foot pedal, and encrypted lap top) will be requested 
for borrowing from department. Photocopying and printing (including white paper) will 
come at an estimated cost of £ 19.75. Refer to Equipment & Cost Form (Appendix 9). 
 
Timetable 
1. Finalise initial interview protocol April 2013 
2. Clinical Psychology Interviews  May – June 2013  
3. Mental Health Staff Interviews  August – October 2013  
4. User and Carer interviews  January – February 2014 
5.  Final data analysis   March – April 2014 
6. Final draft of report   June 2014     
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Practical Applications 
Exploration of using team formulation is hoped to yield valuable insight into its 
effectiveness and value to improve outcomes for difficult to engage service-users within 
the context of an early intervention service for first episode psychosis. It may give 
important indicators on how to optimize the delivery of this approach there. Furthermore, 
the outcomes can inform the development of theory to promote dissemination of this 
approach to other services and also enable the development of a training package to help 
mental health staff, service users and families work together to develop service models 
that enable individualised and collaborative care planning. On a wider scale, it can provide 
additional support and help advance the evidence-base for use of formulation within 
teams.  
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Appendix 2.7: – Plain English summary 
 
Title 
Constructing shared understanding - A grounded theory exploration of team case 
formulation from multiple perspectives  
 
Background 
Case formulation (CF) is a way of making sense of a person’s current problems 
based on an individualised understanding of their sources of strength and 
resilience, development, life history, relationships, coping, current social and 
cultural context. CF is central to planning psychological therapies. Increasingly, CF is 
being used by multidisciplinary teams as an alternative or as an addition to 
diagnosis to provide a more comprehensive understanding of a person in order to 
better plan care. There has been little research into the use of team formulation 
and how this is experienced by mental health staff and service-users.  
 
Research Aim 
The aim of the current study was to explore experiences of CF from multiple 
perspectives within a service that promotes a formulation-based approach within 
their team.  
 
Methods 
Fifteen participants were recruited from the ESTEEM First Episode Psychosis Service 
in Glasgow. The participants were clinical psychologists, mental health staff and 
service-users. Inclusion criteria required that all participants were or have been 
involved with ESTEEM, and were able to consent to and participate in the study.  
 
This was a qualitative study using Grounded Theory (GT) methodology. Qualitative 
research involves analysis of data such as words (e.g. from interviews) as opposed 
to numbers. It gives insight into people’s actual experiences. In this study, the 
researcher collected data by interviewing participants individually.  Staff 
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experiences of CF and service-users experiences of recovery in the context of the 
service were explored. The interviews were recorded, transcribed and analysed 
using GT. GT is a systematic method that aims to generate a theoretical 
understanding to explain how an aspect of the social world “works”. It does not 
start with a hypothesis but allows meaning to be constructed jointly by the 
researcher and the participants. Analysis includes the identification of themes in 
the data that help advance the understanding of the phenomenon under study.  
 
Main Findings  
By exploring participants’ experiences, this study gave insight into the value and 
function of team formulation as well as processes involved in it. Team formulation 
was seen to help the team support service-users that struggle to engage with the 
service and treatment and are therefore at risk of poorer recovery. Gaining a fuller 
understanding of a service-user and broadening the team’s perspectives was seen 
to lead to more flexible, consistent and empathic responding, facilitating person-
centred care planning and the establishment of better relationships with service-
users. The study indicated that doing team formulation was not always easy for 
staff due to uncertainties around what was expected of them in this process and 
having to accept that CF offers a hypothesis about the causes and maintaining 
factors of a person’s problems and do not always reflect a “truth”. In this way CF is 
continually revised and updated. The data indicated the importance of a space that 
allows staff to articulate these concerns, and helps to clarify role expectations to 
arrive at a shared understanding of team formulation and its processes.  
 
Conclusions 
The understanding derived from this study can provide a foundation for a more 
comprehensive theory of team formulation that is needed to support further 
research and help improve, develop and disseminating this practice to other 
services. 
 
 
